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ABSTRACT

Author: Garner, Ron, T. PhD
Institution: Purdue University
Degree Received: August 2018
Title: Acute Effects of Contractile Activity on Skeletal Muscle Exosomes
Major Professor: Timothy P. Gavin
Introduction: Skeletal muscle functions as an endocrine organ, and a key way to
accomplish that is through exosomes. The internal budding of a multivesicular body
(MVB) forms exosomes and contains mRNA, miRNA, and proteins.

Through a

multifaceted approach, the following three experiments were designed to better understand
the effect of contractile activity on skeletal muscle MVB/exosome biogenesis and release.
Study 1: Exosome-related pathway response to acute exercise. Sedentary, lean,
healthy male subjects (n=12) performed 45 min cycling (AEx), followed by single leg knee
extensor exercise (A+REx). A biopsy was obtained prior to exercise and 1 hr post-exercise
from each leg. Stimulation of MVB biogenesis occurred in the A+REx group, with miRNA
biogenesis activated by both AEx and A+REx. Overall, there appeared to be no additive
effect of REx for angiogenesis or mitochondrial improvements following acute exercise.
Our data displays no total protein changes for known exosome surface markers. Increased
MVB biogenesis and release indicate exciting possibilities for exercise stimulated exosome
release.
Study 2:

Effects of obesity and acute resistance exercise on skeletal muscle

intercellular communication pathways. To more fully determine the effect of resistance
exercise (REx) alone on MVB/exosome signaling and obesity on skeletal muscle
angiogenesis, the following study was performed: Lean (LN) and obese (OB) (n=8 each
group) sedentary human subjects performed single leg knee extension exercise at 80% 1RM, 3 sets, 8-12 reps. Muscle biopsies were obtained at rest, 15 min, and 3 hr postexercise. With OB, baseline anti-angiogenic miRNA and diminished MVB biogenesis
were displayed, along with an increased anti-angiogenic factor thrombospondin-1 in
response to acute REx, indicating plausible pathways to explain diminished capillary
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density of Type II muscle fibers. No total changes were observed in VEGF between LN
and OB, though a trend for reduced VEGF existed in the OB group compared to LN.
Study 3: Role of CaMKII in skeletal muscle exosome release. To determine a
candidate pathway linked with calcium signaling, muscle contraction, and exosome
release, specific attention was given to the role of calcium-calmodulin kinase II (CaMKII).
Skeletal muscle biopsies were obtained from lean, healthy, male college-aged subjects
(n=8) and satellite cells isolated for use in cell culture (SkMCC). To ensure proper
differentiation, SkMCC had markers Pax7, Myogenin (MyoG), and myosin heavy chain
(MHC) measured via Western blot on days 0, 2, 4, 6, and 8. SkMCC were stimulated for
30 min with electrical pulse stimulation (EPS), an exercise mimetic, to validate activation
of in vivo exercise pathways adenosine monophosphate kinase (AMPK), mitogen activated
protein kinase (MAPK) and CaMKII. SkMCC underwent 24 h of EPS with and without
the addition of KN-93, a chemical inhibitor of CaMKII.

Quantification of isolated

exosomes following EPS was accomplished by use of a NanoSight, RT-PCR, and Western
blot analysis. The main finding, despite an identifiable change in MHC and formation of
myotubes, minimized contractile activity in vitro leading to inadequate activation of
metabolic pathways and MVB release. Strong trends for the phosphorylation of AMPK,
interaction of CaMKII with clathrin gene expression, reduced gene expression of PDK4,
and reduced total nanoparticles in response to EPS indicate that changes occurred, though
not to the anticipated levels based on preliminary data.
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CHAPTER 1. REVIEW OF THE LITERATURE

Introduction (Review of Literature)
Physical inactivity is a pervasive health problem. It is well documented that regular
physical activity reduces the risk for several diseases including cardiovascular disease
(CVD) (60), obesity, type 2 diabetes (T2D), and some forms of cancer, yet only 1 in 5
Americans meet the 2008 Physical Activity Guidelines (9). Inadequate physical activity is
associated with an estimated $131 billion in health care expenditures (9). This review will
address several issues on health including aerobic and resistance exercise, skeletal muscle
cell signaling, and the impact of obesity.
Obesity
Obesity rates in the United States continue to be a prevalent issue. Despite concentrated
efforts to increase awareness of physical activity, diet, health, and wellness, the obesity
rate continues to increase. From 2000 to 2016, the rate of obesity has increased from 30.5%
to 39.6% of adults in the U.S. (21). Obesity is associated with increased risk for a host of
factors related to the metabolic syndrome, such as dyslipidemia, impaired fasting glucose,
hypertension, and insulin resistance (13). A common dysfunction in these conditions is
impaired extracellular communication, which may lead to an increased risk of T2D (19,
24). Exercise is a well-known intervention to reduce the rates of obesity (64). However,
impaired intercellular communication observed with obesity could limit the effects of
exercise.
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Aerobic Exercise
Aerobic exercise reduces the risk of CVD (60) and increases total aerobic capacity. A
long-term clinical study showed that every 1-metabolic equivalent (3.5 ml O2 x kg-1 x
min-1) increase in aerobic capacity came a 12% improvement in survival (31). The
protective benefits of physical activity and exercise are well displayed in this study, even
in subjects with known CVD. Aerobic exercise also reduces abdominal fat, even without
total weight loss, a risk factor for CVD associated with obesity (49).
Skeletal muscle represents 40% of body weight and approximately the same metabolic
energy use (70). Activation of skeletal muscle in response to exercise causes several cellsignaling cascades to occur, including adenosine monophosphate kinase (AMPK), which
activates fatty acid oxidation and glucose transport to maintain energy demands (23).
AMPK activation also stimulates angiogenesis, control of food intake and whole-body
energy expenditure, and mitochondrial biogenesis (45). Activation of mitogen activated
protein kinases (MAPK) also stimulates glucose and fatty acid oxidation. The isoforms of
MAPK have been shown to be differentially activated based on the intensity and duration
of exercise (27). These are important factors to understand differing responses of MAPK
to various exercise interventions. Exercise-stimulated pathways shown in vivo related to
calcium signaling include CaMKII (1, 47, 48), AMPK (45), and MAPK (27).
Using omics (proteomics, genomics, etc.) analysis of individual exercise bouts helps to
reveal large pieces of information which were previously poorly understood. Single
muscle fiber analysis of contraction-mediated skeletal muscle analysis has identified over
48 individual myokines released following exercise (40). The release of myokines will
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also vary based on fitness level (55). These insights aid future experimental designs for
subject recruitment, outcomes, and the intensity of an exercise intervention.
Resistance Exercise
The primary results from performing resistance exercise training is increased muscle
mass, strength, and power through hypertrophy signaling. Increased muscle mass increases
basal metabolic rate (42). However, with age, muscle mass begins to decline (12) and
adiposity increase (66).

Maintaining muscle mass over the lifetime is an important

principle to reduce obesity and maintain activities of daily living, enjoying a higher quality
of life (44).
Skeletal muscle hypertrophy signaling is well established through the IGF1/AKT/mTOR pathway (54). The phosphorylation of P70S6 kinase, downstream of the
mTOR signaling cascade, is correlated with the phenotypical changes of muscle
hypertrophy (4).

As with aerobic exercise, increased technology and precision of

measuring the outcomes of resistance training focuses on individual proteins altered, based
on intensity.

Some of these outcomes include muscle remodeling, immune system

modulation, and regeneration of the extracellular matrix of skeletal muscle (40).
Skeletal Muscle as an Endocrine Organ
Myokines, which are cytokines or other peptides released by skeletal muscle, can act
in a paracrine or endocrine-like fashion to surrounding tissue (38). Aerobic exercise is a
known stimulus to release myokines through contraction (38, 39). Myokines, including
the interleukin family and myostatin, are released to enhance metabolism, immune system
health, and are pro-inflammatory in their effect (38).
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Exosomes
Another method for cell to cell communication is via exosomes, small vesicles (30100nm) released by tissues such as mast and epithelial cells (28). These vesicles contain
proteins, mRNA and miRNA which can regulate target tissues. For example, skeletal
muscle myotube derived exosomes decrease myoblast proliferation by downregulating the
cell cycle protein cyclin D and increase myoblast differentiation by upregulating the
muscle development and repair protein myogenin (16, 17).
Exosome Biogenesis
Exosomes form from the internal budding of a multivesicular body (MVB), housed
within the cell membrane. The formation of MVB’s entails the endosomal sorting complex
required for transport (ESCRT) proteins which have four complexes: ESCRT-0, I, II, and
III. ESCRT-0 is responsible for recognition and sequestering of ubiquitinylated proteins
and associates with several well-known accessory proteins, including signal transducing
adaptor molecule (STAM), hepatocyte growth factor-regulated tyrosine kinase substrate
(HGS) and tumor susceptibility gene 101 (TSG-101) (11, 58).
As part of the ESCRT-I complex, TSG-101 is most commonly known as a marker of
exosomes and recruits either the apoptotic linked gene-2 interacting protein X (Alix)
protein or the ESCRT-II complex (11, 26, 57). Alix or ESCRT-II will then recruit ESCRTIII, which is primarily responsible for scission of the MVB within the cell membrane (65).
Once fused with the plasma membrane, exosomes are released (7, 26). MVB’s not released
from the cell are degraded by a trafficking protein, vacuolar protein sorting mutant (Vps4a),
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from the AAA ATPase family (5). Increased Vps4a would indicate increased degradation
of MVB’s, reducing the potential for exosome formation.
Exosome Release
Exosome production and release is a coordinated and well-documented process (3, 20,
46). The Rab family has been identified as a key player in the release of the vesicles from
tissue, including MVB’s (37). Specific family members include Rab11, 27a, 27b, 35, and
Syntaxin 1A. MVB fusion with the plasma membrane (and subsequent exosome release)
is increased in response to altered pH, hypoxia, and oxidative stress, all of which are altered
in response to exercise (46). Increased expression of the Rab family indicates increased
activity at the endosome, potentially leading to more exosome release.
Exosome Content
The content of individual exosomes will determine the effect in target tissues.
Exosomes may be “antigen containing,” effecting immune system response (28, 59) or
“RNA containing,” effecting functions based on the RNA encased (22, 28, 62). The
previous references indicate a range of exosome content which include whole proteins,
messenger RNA (mRNA) or exosomal shuttle RNA (esRNA, micro RNA (miR), small
interfering RNA, and interfering RNA.

Each play critical roles in cell-to-cell

communication. An esRNA is a mRNA which is “shuttled” from one tissue to another and
retains the ability to transcribe protein in the new tissue (62). miRNA, which are short
(~20 nucleotides) non-protein coding RNA, can effectively block protein transcription by
binding to or cleaving mRNA. This blocks mRNA in post-transcriptional modification or
an “epigenetic” fashion (14). Additionally, the selection of miRNA is not random, but
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certain miR will be given preferential packaging using methods that are still not entirely
known (20, 67).
microRNA
Specific miR known to impact muscle function continue to be understood. Those of
paramount importance to this review include miR related to angiogenesis, muscle function,
or known exercise responses. Angiogenesis is decreased with miR-206 and miR-503 by
impacting VEGF and NFκB expression (25, 56) and miR-503 directly downregulates FGF2
and VEGFα gene expression (69). Increased miR-503 expression contributes to impaired
angiogenesis observed in T2DM (8). An angiogenic promoter, miR-130a, blocks the antiangiogenic GAX and HOXA5 homeobox genes in vascular endothelial cells (10).
Endothelial cells express large levels of miR-126, which is also pro-angiogenic in response
to ischemia-induced angiogenesis (63).
For regular muscle function, miR-181a is expressed during skeletal muscle
differentiation as a negative feedback system, which downregulates Hox11A and represses
the differentiation process (32). Mature skeletal muscle cells deficient of miR-133a are
associated with decreased mitochondrial function and impaired exercise tolerance (33).
This helps to identify potential targets and benefits of miR in response to exercise. Several
reports have identified skeletal muscle miRNA altered in response to acute exercise at
various time points (34, 50, 51, 61).
Exosome Cross-Talk
Documentation of skeletal muscle exosome release in humans has been limited. Prior
research has shown MVB’s released into the circulation in young, healthy, physically
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active men in a dose-response manner following maximal cycling and running exercise
(18). However, the samples collected were serum MVB’s, which limit our ability to
determine any specific release from skeletal muscle. In a recent review of exosomes and
MVB’s, it was shown that immediately after aerobic exercise, there is lower expression of
Alix in exercised compared to sedentary mice (52). Alix has been identified as a calciumdependent pathway with the ESCRT-III pathway (30). With a large amount of calcium
released from the sarcoplasmic reticulum in skeletal muscle, evidence would suggest a
potential calcium pathway related to muscle contraction and exosome release.
It is well known that obese individuals have high macrophage activity and chronic
inflammation (41). Physical activity can reduce this inflammation state associated with
obesity (6). One source where chronic inflammation can occur is from exosomes released
by adipocytes, which led to increased macrophage activity (68). Macrophages increase
common inflammatory markers observed with obesity; tumor necrosis factor-α (TNF-α),
interleukin-6 (IL-6), and nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-Kβ), all of which reduce insulin sensitivity (29). Mice fed a high fat diet released
skeletal muscle exosomes which transferred the deleterious effects of insulin resistance and
were incorporated in metabolic tissues, the liver and pancreas (2). In humans, exosomes
contained 55 differentially expressed miRNA in obese compared to lean, focusing
primarily on the TGF-β and Wnt/β-Catenin pathways (15). These pathways are involved
in increased inflammation and altered cell signaling. Altogether, these articles display that
exosomes in obesity may alter insulin signaling, inflammation, and negatively affect
paracrine-like signaling to adjacent tissues in vitro and in vivo.
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Electrical Pulse Stimulation
Primary human muscle cultures are powerful tools to understand cellular phenotypes.
There are advantages and drawbacks to each type of experimental approach, including
comparisons of in vitro to in vivo responses to similar stimuli (36). An advantage to using
in vitro modeling systems with skeletal muscle is the knowledge that what is released from
muscle can be captured and accurately identified.
Using an in vitro model for exercise through electrical pulse stimulation (EPS) is well
established (35, 53). Recent work in mouse primary skeletal muscle cells as well as C2C12
cells, an immortalized murine skeletal muscle cell line, has shown that exosomes isolated
from myotubes will suppress myoblast expression (17). The ability to isolate exosomes
from skeletal muscle to use as treatment allows powerful information on intrinsic and
extrinsic control or “cross-talk” between cells (16).
Hypothesis
It was hypothesized that acute exercise stimulates the biogenesis of MVB’s.
Additionally, it was hypothesized that reduced exosome production occurs in response to
acute exercise in obesity compared to normal weight subjects. To test our hypothesis, the
following three studies were performed:
1. Skeletal muscle exosome response to acute aerobic and concurrent exercise.
2. Skeletal muscle exosome and angiogenic miRNA response to acute resistance
exercise in lean and obese men and women.
3. In vitro mechanistic analysis of skeletal muscle exosome release in primary human
skeletal muscle cells via electrical pulse stimulation (EPS).
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CHAPTER 2. EXOSOME AND EXOSOME-RELATED PATHWAY
RESPONSES TO ACUTE EXERCISE

Ron T Garner1, Jessica S Solfest1, Yaohui Nie1, Shihuan Kuang2, Julianne Stout3, Timothy
P Gavin1
1

Department of Health and Kinesiology and Max E. Wastl Human Performance
Laboratory, Purdue University, West Lafayette, IN
2
Department of Animal Science, Purdue University, West Lafayette, IN
3
Indiana University School of Medicine–West Lafayette, West Lafayette, IN

Corresponding Author: Timothy P Gavin, Purdue University, Health and Kinesiology
Department, 800 West Stadium Avenue, West Lafayette, IN, 47906.
Email: gavin1@purdue.edu
Abstract
Introduction: Exercise training promotes beneficial adaptations and recommendations
for activity include aerobic (AEx) and resistance (REx) exercise on most days of the week.
A potential method of communication in response to exercise includes microvesicles,
particularly exosomes, which contain mRNA, miRNA, and proteins. Exosomes are known
to regulate transcription in target tissues and would be a viable signaling mechanism
following exercise. However, little is known about exosome biosynthesis and release
following varied types of exercise. Our hypothesis is that 1) skeletal muscle exosomes are
released in response to AEx and concurrent (A+REx) exercise and 2) contain musclespecific miRNA used to enhance angiogenesis.
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Methods: Twelve sedentary, healthy male subjects (21.6 ± 1.8 years) exercised on a
cycle ergometer for 45 minutes (AEx) followed by single leg knee extensor exercise
(A+REx). Muscle biopsies were obtained from the vastus lateralis in a single leg at rest
and one-hour post-exercise from each leg. Western blot and rt-PCR analysis of known
multivesicular body (MVB) biogenesis, release, and cell surface markers as well as miRNA
machinery and mitochondrial and angiogenic factors were measured. miRNA related to
angiogenesis (miRNA’s 126, 130a, 133a, 206, and 503) were also measured. Data were
compared using one-way repeated measures ANOVA and Pearson Correlations.
Results: MVB biogenesis was increased for clathrin and alix, with trends in other MVB
complexes and CD-63 in response to A+REx. No change in the release pathway in
response to AEx or A+REx, but trends for increased expression are observed. Whole
muscle protein analysis showed no changes in alix, TSG-101, or CD-63. Gene expression
increased for VEGF and PGC-1a, indicating an angiogenic and mitochondrial response to
AEx and A+REx. miRNA processing pathway exportin-5 and dicer increased following
each exercise condition.
Conclusion: Our data displays increased gene expression for select MVB biogenesis
markers, trends for increased gene expression of MVB release, yet no total protein changes
for known exosome surface markers. Although total protein of exosome surface markers
were unchanged, increased gene expression of MVB biogenesis indicates an exciting
possibility for an exercise-induced pathway to potential exosome release.

Keywords: Exosomes, miRNA, Concurrent, angiogenesis
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Introduction
Skeletal muscle represents 30-40% of body mass and metabolic energy use (49) and
participates in intercellular communication in part via myokines, muscle released cytokines
(32, 33). There is mounting evidence that many cell types including skeletal muscle also
communicate via the release of exosomes, 30-100 nm microvesicles containing proteins,
mRNA and miRNA that regulate other cells function (26). Skeletal muscle myotube
derived exosomes decrease myoblast proliferation by downregulating the cell cycle
protein, cyclin D, and increase myoblast differentiation by upregulating the muscle
development and repair protein, myogenin (11, 12). Injected C2C12 myotube-derived
exosomes can be incorporated into metabolic tissues such as the liver and pancreas in mice
(1). These reports establish skeletal muscle exosomes as a potential source for paracrine
and endocrine signaling, however data on the regulation of exosome biogenesis in humans
is limited (38).
Exosome biogenesis occurs from the internal budding of multivesicular bodies (MVB)
via four protein complexes known as the endosomal sorting complex required for transport
(ESCRT) 0, I, II, and III (Figure 1) (8).

ESCRT-0 recognizes and sequesters

ubiquitinylated proteins and associates with the accessory proteins signal transducing
adaptor molecule (STAM), hepatocyte growth factor-regulated tyrosine kinase substrate
(HGS), and tumor susceptibility gene 101 (TSG-101) (8, 43). As part of the ESCRT-I
complex, TSG-101 recruits either the apoptotic linked gene-2 interacting protein X (Alix)
or the ESCRT-II complex (8, 23, 42). Alix or ESCRT-II then recruits ESCRT-III, which
is primarily responsible for scission of the MVB within the cell membrane (48) resulting
in MVB fusion with the plasma membrane and exosome release (4, 23). MVBs not fused
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with the cell are degraded by a trafficking protein, vacuolar protein sorting mutant (Vps4a,
Vps4B) in complex with vesicle trafficking 1 (Vta1) (3, 21).
Exosome release from the cell is a coordinated and well-documented process (2, 20,
34) and occurs through MVB fusion to the plasma membrane via soluble NSF attachment
protein receptor complexes (SNARE) (2). Rab proteins are known to regulate SNARE
protein function through direct or indirect contact (5, 22). Specific members of the Rab
family identified with MVB/exosome regulation include Rab11, 27a, 27b, 35, and the
syntaxin family gene Syntaxin 1A (2, 31). Increased expression of Rab and syntaxin
families indicates increased activity at the endosome, the location of MVB biogenesis (23,
31). As MVB biogenesis and release increases, miRNA content may also increase. To
produce mature miRNA, primary and pre miRNA are formed by drosha and pasha in the
nucleus, pre-miRNA are then transported to the cytoplasm by exportin-5, and pre-miRNA
are cleaved by dicer to form mature miRNA (10).
Regular physical activity reduces the risk of several chronic diseases (45). Previous
work from our laboratory on the angiogenic myokine vascular endothelial growth factor
(VEGF) found rapid increases in VEGF mRNA in response to both acute AEx (17) and
REx (15) as well as the secretion of VEGF during acute AEx (18). VEGF is important for
muscle basal capillarization and angiogenesis in response to exercise (29, 30).
Interestingly, cardiac muscle progenitor cells are known to secrete angiogenic exosomes
in response to hypoxia (19). Recent work suggests acute AEx increases circulating MVB’s
(47), however little information exists on the response of the muscle microvesicle pathways
in response to acute exercise.
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In the current report, we investigated if acute exercise increases expression of MVB
biogenesis and release pathways. With miRNA being important constituents of exosomes,
the expression of the miRNA processing pathway and selected miRNA in skeletal muscle
were investigated. Finally, given current interests in concurrent exercise, responses to
acute aerobic (AEx) and aerobic+resistance (A+REx) were analyzed. It was hypothesized
that skeletal muscle MVB biogenesis increases in response to acute aerobic and concurrent
exercise.

Additionally, it was hypothesized that acute exercise increases miRNA

processing proteins as well as specific miRNA related to angiogenesis and muscle function
in response to acute aerobic and concurrent exercise.
Methods
Subjects. Twelve sedentary, young (18-30 y of age) men volunteered to participate
after an explanation of the study and informed consent approved by the University
Institutional Review Board. All subjects were healthy non-smokers, with no history of
cardiopulmonary disease. Sedentary subjects were defined as participating in less than 1
hr of strenuous physical activity per week. Subject characteristics are listed in Table 1.
Determination of V̇O2MAX and 1-RM. Maximal oxygen consumption (V̇O2MAX) was
measured on an electronically braked cycle ergometer (Lode, Excaliber Sport, Groningen,
Netherlands) as previously described (24). Minute ventilation (V̇E), oxygen uptake (V̇O2),
and carbon dioxide production (V̇CO2) were continuously monitored via open circuit
spirometry (True Max 2400, Parvo Medics, Salt Lake City, UT). Heart rate (model T31,
Polar Electro Inc., Woodbury, NY) and rating of perceived exertion (RPE) were measured
continuously. The test began with a 5-min warm-up at 50W, following which workload
increased 25W every min until volitional fatigue. Subjects were verbally encouraged to
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continue for as long as possible. The criterion used to assess V̇O2MAX included: 1) a heart
rate in excess of 90% of age predicted max (220 - age); 2) a respiratory exchange ratio
greater than or equal to 1.10; and 3) identification of a plateau (< 150 ml/min increase) in
V̇O2 despite a further increase in workload. In all tests, at least two of three criteria were
met.
After a 15-min rest period following the V̇O2MAX test, single leg knee extensor (KE)
one repetition maximum (1-RM) was determined for the dominant leg. The initial weight
of 13.6 kg was progressively increased by 4.5 kg until they were unable to continue.
Subjects were given 1 min rest between each attempt. The highest successfully lifted
weight was designated as 1-RM.
Experimental design. At least two weeks after the determination of V̇O2MAX and 1RM, subjects reported to the Max E. Wastl Human Performance Laboratory between 0600
and 0700 after a 12 hr fast. Subjects performed 45 min of two-legged cycle ergometry at
55% of V̇O2MAX. Directly following AEx, subjects completed single leg KE exercise, three
sets of 8-12 repetitions at 55% of the 1-RM workload, with a 2-min rest interval between
sets (A+REx). Given VEGF mRNA is increased 2-fold and 4-fold at 0 and 2 hr after
aerobic exercise (17) and increases in circulating exosomes occur at 1 hr after aerobic
exercise (47), we investigated responses from vastus lateralis biopsies prior to and 1 hr
after the acute AEx and A+REx bouts. The initial, resting biopsy was alternated between
AEx and A+REx legs across subjects. Biopsies for AEx and A+REx were alternated
between being the 2nd and 3rd biopsy across subjects to minimize potential time bias postexercise. Biopsies (rest and acute exercise) when taken from the same leg were separated
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by at least 3 cm as previously described (15, 17). Samples were stored at –80 oC until
analysis.
Quantitative real-time PCR. Total RNA from skeletal muscle was isolated using Trizol
reagent (Invitrogen, Carlsbad, CA). For mRNA reverse transcription, first-strand cDNA
was generated by random hexamer primers with MMLV Reverse Transcriptase
(Invitrogen). For mature miRNA reverse transcription, multiple adenosine nucleotides
were first added to the 3’ end of the total RNA with Escherichia Coli DNA polymerase
(New England BioLabs, Ipswich, MA) and cDNA was then synthesized with a Poly T
primer including an adaptor sequence using MMLV Reverse Transcriptase. To determine
mature miRNA, the specific miRNA sequence was used as the forward primer and the
adapter sequence from the Poly T primer was used as the universal reverse primer for all
miRNAs. Real-time PCR reactions were performed with a SYBR green PCR kit in a Roche
LightCycler® 480 System (Roche, Indianapolis, IN). Gene expression was determined
with the 2-ΔΔCt relative quantification method and was normalized to 18s for mRNA or
RNU24 for miRNA (25). Primer sequences are listed in Table 2. Due to inadequate muscle
sampling, one subject was excluded from all gene expression analysis (n=11)
Muscle protein isolation and analysis. Twenty mg of frozen muscle was homogenized
on ice in RIPA buffer (50mm Tris HCL 7.4 pH, 150mm NaCl, 2mm EDTA, 0.1% SDS,
0.1% Triton x-100, 0.5% NaDeoxycholate) using a handheld variable speed homogenizer
(LabGEN7, Cole-Palmer, Vernon Hills, IL). Phosphatase inhibitors (0.2 mM Na 3VO4, 50
mM NaF) and a protease inhibitor cocktail (P8340, Sigma-Aldrich, St. Louis, MO) were
added to prevent modification of proteins post-homogenization. Total sample protein
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concentration was determined by the bicinchoninic acid method (BCA protein assay kit,
Bio-Rad Laboratories, Hercules, CA).
From muscle homogenates, 30-60 µg of total protein was fractionated for Western blot
analysis on SDS-polyacrylamide gels, transferred to reduced-fluorescence PVDF
membrane, and incubated with one of the following primary antibodies: Alix (#2171s, Cell
Signaling Technology), TSG-101 (#sc-7964, Santa Cruz Biotechnology), and CD-63 (#sc5275, Santa Cruz). Either florescence-conjugated (#925-32210, LI-COR) or horseradish
peroxide–conjugated (#7074 Anti-Rabbit, #7076 Anti-Mouse, Cell Signaling) secondary
antibodies were incubated with the membrane and detected using florescence (Odyssey,
LI-COR,

Lincoln, NE) or chemiluminescence (PerkinElmer, Waltham, MA).

Densitometric analysis was performed manually using Image J (SciJava) or Image Lab
software (Bio-Rad). Results were normalized to alpha tubulin (#2144, Cell Signaling).
Statistical Treatment. One-way repeated measures analysis of variance (ANOVA) was
used. Following a significant F ratio, a Fisher’s LSD was used. Pearson correlations were
performed to investigate relationships between variables. Significance was established at
p ≤ 0.05 for all statistical sets and data reported are Mean ± SE.
Results
MVB biogenesis and release pathways. To assess the MVB biogenesis pathway in
response to exercise, key components in the formation of MVB’s (HGS, clathrin, TSG101, Alix, STAM, VTA1, VSP4a) were analyzed using rt-PCR analysis. Clathrin and alix
mRNA were increased in response to exercise (Figure 2). Post-hoc analysis identified
increases in clathrin and alix mRNA following A+REx. There was a trend toward
increased gene expression for HGS where A+REx increased ~25%.

There was no
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difference in mRNA for CD-63, TSG-101, STAM, VTA1, or VPS4a in response to
exercise.
To investigate an increase in MVB release following acute exercise, gene expression
for Rab family (Rab11A, 27A, 27B, 35) and Syntaxin1A proteins were analyzed (Figure
3). A trend for increased gene expression for Rab27A and Rab35 was observed, where
A+REx increased ~60% and ~40% respectively. There was no change in Rab11A,
Rab27B, or Syntaxin1A in response to acute exercise.
Exosome surface marker protein expression. To determine MVB/exosome release in
response to acute exercise, exosome surface marker and MVB biogenesis protein levels
(alix, CD-63, TSG-101) were measured before and after acute exercise via Western blot
analysis. At 1 hr post-exercise, there were no differences identified for protein expression
in AEx or A+REx conditions for alix, TSG-101, or CD-63 (Figure 4).
miRNA biogenesis processing. Essential parts of the miRNA biogenesis pathway
include drosha, exportin-5, and dicer. The mRNA for dicer and exportin-5 were increased,
with no change in drosha (Figure 5). Post-hoc analysis identified increased dicer and
exportin-5 with AEx and A+REx. These data suggest a coordinated response of the
transport of pre-miRNA from the nucleus and the processing of mature miRNA in skeletal
muscle. Pearson correlation analysis revealed relationships between exosome surface
markers and miRNA processing in both AEx and A+REx conditions, consistent with
potential coordination between miRNA and MVB expression (Table 3). No relationships
were identified between MVB biogenesis/release pathways and the miRNA processing
pathway.
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Angiogenic and mitochondrial mRNA and miRNA. To explore the acute response of
angiogenesis and mitochondria 1 hr post-exercise, the gene expression of VEGF and PGC1α was examined. Both VEGF and PGC-1α were increased ~5-fold by AEx and A+REx,
suggesting no additive effect with REx. There were no changes in response to exercise in
angiogenic (miR-126, -130a, -206, and -503) or mitochondrial (miR-133a) miRNA (Figure
6). A moderate negative correlation was observed between V̇O2Max and miR-130a AEx
(r=-0.63; p=0.04) (data not shown).
Discussion
In the current report, we investigated if acute, moderate intensity cycling exercise with
or without the addition of REx increases components of the exosome pathway: MVB
formation, MVB fusion/exosome release, exosome surface markers, and miRNA. We
identified increases in the gene expression of components of MVB biogenesis (alix and
clathrin) and miRNA processing (exportin-5 and dicer), but no changes in MVB release.
MVB biogenesis and release. There are over 23 proteins associated with the ESCRT
exosome biogenesis pathway (8). In the current report, key components in each of the
ESCRT pathway complexes were analyzed to identify potential changes in MVB
biogenesis in response to acute exercise. Increased gene expression was observed for
clathrin and alix, an early phase of MVB biogenesis and accessory protein, which may
indicate a response of MVB biogenesis following acute exercise in humans.
Microvesicles increased in circulation immediately following maximal cycling
exercise in humans (13), and visual evidence demonstrated reduced skeletal muscle alix
protein immediately following submaximal exercise in mice (38). Despite this evidence,
the present investigation observed no change in alix total protein 1 hr post-exercise.
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However, increased gene expression of alix and clathrin and trends for increased HGS
(~25%) and STAM (~25%) following A+REx identify stimulation of the MVB biogenesis
pathway. Although alix total protein did not change, increased gene expression for alix
may indicate any changes which occurred returned to baseline 1 hr post-exercise.
Compared to the former studies, subjects completed submaximal cycling efforts (55%
V̇O2MAX) and samples were not obtained immediately post-exercise. Based on this finding,
future studies should increase exercise intensity and collect samples immediately postexercise to fully identify alterations of MVB biogenesis in human skeletal muscle.
In K562 and T-cells, calcium is important in exosome release (40, 41). Rab11 is
associated with MVB release and calcium dependent pathways (39). As calcium release
and sequestration are required for skeletal muscle contraction, a potential signaling
pathway in human skeletal muscle exosome release is identified through Rab and syntaxin
family proteins. However, gene expression of Rab and Syntaxin family proteins was
unchanged in the present study. A trend for increased gene expression of Rab27A (~55%)
and Rab35 (~40%) were displayed with A+REx. As there are no known time course studies
related to the release of skeletal muscle exosomes, future studies should include specific
acute exercise effects on the timing of MVB biogenesis and release (AEx, REx, A+REx,
etc.).
Exosome surface marker identification.

Exosome surface markers may be more

important than we have understood to this point to identify function or size of particles.
Several reports discuss varying surface markers for microparticles (8, 38, 44). Alix and
CD-63 are released in different volumes from C2C12 myoblasts/myotubes during different
days of differentiation (35). One report noted that when alix was knocked down in vitro,
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released microparticles contained more major histocompatibility complex II components,
which alters the size of the vesicle (8). Taken together, these data indicate exosome
markers may be associated with a specific function or released in response to a specific
stimulus (i.e. AEx vs. A+REx). The understanding gained from the current investigation
for gene or protein expression in response to AEx and A+REx could be altered based on
the exosome marker selected. To avoid this, we analyzed several commonly known
markers of exosomes in whole muscle homogenates. A differential regulation of exosome
sub-type based on size or surface marker could show exciting possibilities of altered
exosome release based on the type of activity performed or content contained therein.
miRNA biogenesis. Following 60 min of acute cycling exercise, drosha, exportin-5,
and dicer gene expression were increased ~30-35% 3-hours post-exercise (36). Consistent
with this data, gene expression for exportin-5 and dicer were increased 1 hr post-exercise
in the current report. In conjunction with increased miRNA biogenesis, there was a
coordinated gene expression response to AEx and A+REx (Table 3) with exosome surface
markers/MVB biogenesis. Although increases in exosome marker gene expression does
not signify an increase of exosomes in skeletal muscle, it gives evidence that both pathways
(miRNA and MVB’s) may be activated by an acute exercise stimulus.
Exercise, muscle, angiogenesis, and mitochondria. It is well known that exercise leads
to increased expression of VEGF and PGC-1α (14, 16, 27). Prior research has identified
increased VEGF in response to AEx or REx alone and known responses occur 2 hr postexercise (15, 16). The data herein demonstrates that VEGF gene expression is increased
at 1 hr post-exercise and that no additive response occurs with the addition of REx to AEx.
PGC-1α gene expression was also increased 1 hr post-exercise in both conditions. Due to
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this known response, any changes with miRNA measured in the current investigation
should have occurred. This gives confidence that acute AEx and A+REx at the intensity
and time selected does not stimulate known angiogenic (miR-126, -130a, 206, -503) or
mitogenic (miR-133a) miRNA.
Several reports have identified skeletal muscle miRNA altered in response to acute
exercise at various time points (28, 36, 37, 46). In one case, evidence shows altered
miRNA response to resistance training separated by low and high responders to lean body
mass gained during training (9). For the present investigation, a moderate negative
correlation was observed between V̇O2MAX and miR-130a AEx (r=-0.63; p=0.04). This
gives insight into angiogenic potential in subjects with the lowest V̇O2MAX values. miR130a is an angiogenic promoter which blocks the anti-angiogenic GAX and HOXA5
homeobox genes in vascular endothelial cells (7). Subjects with the lowest V̇O2MAX
displayed greater miR130a expression in response to AEx, increasing the angiogenic
response compared to those with normal V̇O2MAX values. No correlations were observed
with V̇O2MAX and VEGF, yet the greater miR-130a identifies a unique potential therapeutic
target to enhance angiogenesis in subjects with diminished V̇O2MAX values. Greater miR503 previously exhibited diminished endothelial cell function (6), however, no
relationships were identified for miR-503 and V̇O2MAX in the current investigation. A
moderate positive correlation was observed with miR-503 Pre and PGC-1α A+REx
response (r=0.57, p=0.01). This indicates that the addition of REx to AEx may help to
stimulate PGC-1α to combat the negative endothelial function at baseline.
In summary, our data display increased gene expression of MVB biogenesis and known
exosome surface markers. In addition, gene expression of enhanced miRNA processing,
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VEGF, and PGC-1α response 1 hr post-exercise identify novel adaptations to acute
exercise. These data indicate exciting potential for exercise stimulated MVB/exosome
biogenesis. The new possibilities to understand skeletal muscle exosome response to
varied exercise type, time, and intensity gives rise to future research.
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Table 1. Subject Characteristics. BMI, body mass index; V̇o2MAX,
maximal oxygen consumption; KE, maximal knee extensor
strength. Mean ± SE. N = 12.

Age, y

Mean ± SE

Range (Min-Max)

22.3 ± 1.7

18-30

Height, m

1.80 ± 0.02

1.73-1.85

Mass, kg

75.5 ± 4.4

57.7-90.9

BMI, kg/m2
.
VO2MAX, l×min-1
.
VO2MAX, ml×kg-1×min-1

23.3 ± 1.4

17.3-29.7

2.93 ± 0.20

1.88-3.68

39.0 ± 4.0

24.6-54.8

KE, kg

35.6 ± 3.1

27.3-50.0

KE, kg×kg-1

0.47 ± 0.04

0.36-0.68
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Table 2. Gene sequences of mRNA and miRNA, obtained from the Harvard Primer Bank.
Apoptotic linked gene-2 interacting protein X (Alix); Tumor Susceptibility Gene-101
(TSG-101); hepatocyte growth factor-regulated tyrosine kinase substrate (HGS); signal
transducing adaptor molecule (STAM); vesicle trafficking 1 (Vta1); vacuolar protein
sorting mutant (Vps4a).
Gene

Forward (5’-3’)

Reverse (5’-3’)

Alix
Clathrin
TSG-101
CD63
Dicer
Exportin5
Drosha
HGS
STAM
VTA1
Vps4a
Rab11A
Rab27A
Rab27B
Rab35
Syntaxin
1A

ATGGCGACATTCATCTCGGTG
ATTCTGCCAATTCGTTTTCAGGA
GAGAGCCAGCTCAAGAAAATGG
CAGTGGTCATCATCGCAGTG
GAGCTGTCCTATCAGATCAGGG
ATCCTGGAACACGTTGTCAAG

CGCTTGGGTAAGTCTGCTGG
GCTTTCAGTGCAATTACTTTGCT
TGAGGTTCATTAGTTCCCTGGA
ATCGAAGCAGTGTGGTTGTTT
ACTTGTTGAGCAACCTGGTTT
CACTACAATTCGAGACAGAGCAT

TGTCACAGAATGTCGTTCCAC
CTCCTGTTGGAGACAGATTGGG
AATCCCTTCGATCAGGATGTTGA
CTCCCCGCACAGTTCAAGAG
CCACGCTATCAAGTATGAGGC
CAACAAGAAGCATCCAGGTTGA
GCTTTGGGAGACTCTGGTGTA
TAGACTTTCGGGAAAAACGTGTG
TACTGTTGCGTTTTGCAGACA
CGAGACCGCTTCATGGATGAG

GGGCCTAAAGGATGGTGCT
GTGTGGGTTCTTGTCGTTGAC
CGAGACTGACCAACTTTATCACA
AACGACAGTAATAAGCCACCAC
CCGTGTTTCTCTTTGCTTCGTA
GCACCTACAGCTCCACGATAAT
TCAATGCCCACTGTTGTGATAAA
AGAAGCTCTGTTGACTGGTGA
CCCCGATAATACGTGGAGGTG
ACTTGGAACGAACTTTGTTTGC

miR
126
130a
133a
206
503

TCGTACCGTGAGTAATAATGCG
CAGTGCAATGTTAAAAGGGCAT
TTTGGTCCCCTTCAACCAGCTG
TGGAATGTAAGGAAGTGTGTGG
TAGCAGCGGGAACAGTTCTGCAG
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Alix mRNA
TSG-101
mRNA
CD63 mRNA

Dicer
mRNA

0.82*
0.75*
0.71*

Exportin-5
mRNA

B.

0.42
0.35
0.73*

Drosha
mRNA

Alix mRNA
TSG-101 mRNA
CD63 mRNA

0.75*
0.71*
0.34

Dicer
mRNA

Drosha
mRNA

A.

Exportin-5
mRNA

Table 3. Pearson correlation values (r) displaying interactions between miRNA processing
and exosome surface markers/MVB biogenesis for AEx (A), and A+REx (B). *p≤0.05.

0.77*

0.75*

0.81*

0.94*

0.77*

0.82*

0.79*

0.28

0.85*
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ESCRT-0
STAM

Clathrin

HGS

TSG-101
ESCRT-1
ALIX

ESCRT-II

ESCRT-III

VPS4a /
VPS4b
Figure 1. Overview of MVB biogenesis pathway. Endosomal complex required for
transport (ESCRT) 0, I, II, and III. Hepatocyte growth factor-regulated tyrosine kinase
substrate (HGS), clathrin, signal transducing adaptor molecule (STAM), tumor
susceptibility gene-101 (TSG-101), apoptotic linked gene-2 interacting protein X
(Alix), and vacuolar protein sorting mutant (Vps4a, Vps4b).
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Figure 2. Gene expression of MVB biogenesis/ESCRT in response to acute aerobic
(AEx) and concurrent (A+REx) exercise. ESCRT-0 proteins hepatocyte growth
factor-regulated tyrosine kinase substrate (HGS) (A) and clathrin (B), signal
transducing adaptor molecule (STAM) (E), ESCRT- I proteins Tumor Susceptibility
Gene-101 (TSG-101) (C), accessory protein Apoptotic linked gene-2 interacting
protein X (Alix) (D), ESCRT-III proteins vesicle trafficking 1 (Vta1) (F), and vacuolar
protein sorting mutant (Vps4a) (G), and tetraspanin CD-63 (H). *p≤0.05 vs Pre;
#p≤0.05 vs AEx. Mean ± SE, n=11.
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Figure 3. Gene expression of MVB/exosome release in response to acute aerobic
(AEx) and concurrent (A+REx) exercise for Rab11 (A), Rab27A (B), Rab27B (C),
Rab35 (D), and Syntaxin1A (E). Rab and syntaxin family proteins are associated with
MVB fusion with the membrane, leading to exosome release. Mean ± SE, n=11.
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Figure 4. Protein analysis of exosome surface markers in response to acute aerobic
(AEx) and concurrent (A+REx) exercise for alix (A), CD-63 (B), and TSG- 101 (C).
Mean ± SE, n=12.
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Figure 5. Gene expression of miRNA processing pathway drosha (A), exportin-5 (B), and
dicer (C) in response to acute aerobic (AEx) and concurrent (A+REx) exercise. *p ≤0.05
vs Pre. Mean ± SE, n=11.
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Figure 6. Analysis of mitochondrial and angiogenic gene expression and miRNA in
response to acute aerobic (AEx) and concurrent (A+REx) exercise. For mitochondrial
function, PGC-1α (A) and miR-133a (B) were measured. For angiogenesis, VEGF (C),
and miR-126 (D), -130a (E), -206 (F) and -503 (G) were measured. *p≤0.05 vs pre. Mean
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Abstract
Introduction: Obesity (OB) continues to be a prevalent cause for concern and disrupts
cellular communication and skeletal muscle capillarization.

Exosomes, small

microvesicles, are known to pass genetic material (mRNA, miRNA) and whole proteins
and are affected by aerobic exercise. Resistance exercise (REx) stimulates angiogenesis
with unknown effects on exosome biogenesis. Additionally, little is known about the
impact of a single bout of REx on angiogenesis. Our hypothesis was that OB impacts basal
exosome biogenesis, and a single bout of REx will stimulate exosome biogenesis and
angiogenesis in LN subjects, but that OB will diminish the REx effect.
Methods: LN (LN) and OB (n=8 each group) sedentary human subjects participated in
the study. Subjects underwent V̇O2MAX and 1-RM testing to establish their fitness level.
On a separate day, subjects performed single leg knee extension exercise at 80% 1-RM, 3
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sets, 8-12 reps. Muscle biopsies were obtained at rest, 15 min, and 3 hr post-exercise.
Histological and chemical analysis of skeletal muscle was performed, including q-PCR,
Western blots, and fiber type and capillary staining.
Results: Basal exosome biogenesis was reduced in OB compared to LN with no REx
effect in either group. Exosome surface marker protein and gene expression was altered in
response to REx in both groups. miRNA related to angiogenesis was altered in obesity at
baseline, with no REx effect. Both groups have intact vascular endothelial growth factor
(VEGF)

response

following

REx,

with

increased

anti-angiogenic

signaling,

thrombospondin-1 (TSP-1) in the OB group. Capillary density in OB subjects is impaired
in Type II muscle fibers.
Discussion:

With obesity, baseline anti-angiogenic miRNA, diminished MVB

biogenesis, and increased TSP-1 in response to acute REx indicate plausible pathways to
explain diminished capillary density of Type II muscle fibers. Variable changes to increase
and decrease exosome surface markers were identified in response to REx, with no changes
in MVB biogenesis in either group. Potential therapeutic targets to improve angiogenesis
in OB should be identified for transport in exosomes, such as miR-206, -503, and 130a.
Key Words: Exosomes, MVB, Angiogenesis
Introduction
Obesity (OB) rates in the United States continue to be a prevalent issue and continue
to rise with an increase from 30.5% to 39.6% of adults between 2000 and 2016 (19). OB
is associated with reduced skeletal muscle oxidative capacity (42), increased insulin
resistance (9), impaired intercellular communication (18, 20), and increased capillary
cross-sectional area and diminished density (17, 32).

This reduces the number of
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capillaries per fiber of OB individuals, limiting the critical role capillaries play in
delivering substrates, such as oxygen, glucose, and insulin to skeletal muscle (25).
Intercellular communication between skeletal muscle fibers and adjacent endothelial
cells is important for capillarization and is regulated by several factors including nitric
oxide (50), vascular endothelial growth factor (VEGF) (12, 45), and thrombospondin-1
(TSP-1) (24). Maintaining proper capillarization ensures adequate diffusion capacity to
skeletal muscle (23) and intercellular communication plays an important role in this
regulation. Skeletal muscle plays a critical role in cross-talk to adjacent tissues through
myokines or “exerkines” released through exercise (37, 40).
In addition to paracrine growth factor regulation, exosomes, 30-100 nm microvesicles,
might also regulate capillarization via cell-to-cell communication in muscle (26, 29). The
effects of obesity with exosome release at baseline and during acute exercise is unknown.
Exosomes are formed from the internal budding of multivesicular bodies (MVB) and
contain mRNA, proteins, and miRNA that vary by cellular source (4). This process entails
coordination of many pathways, including MVB formation with clathrin, TSG-101, and
alix (4), and miRNA processing, drosha, exportin-5, and dicer (10). Angiogenic miRNA
could play a role in basal changes of muscle capillarization by effecting VEGF, such as
miR-130a, -206, and -503 (3, 43, 49).
Previously, our laboratory reported no difference in VEGF at rest between OB and LN
subjects as well as no differences in the VEGF response to acute aerobic exercise (17).
This is consistent with findings that muscle capillarization is increased in response to
aerobic training in OB women (31). Resistance exercise (REx) training is well known to
promote muscle fiber hypertrophy and angiogenesis. Given muscle fiber hypertrophy and
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lower capillary density in obesity (17), responses to acute REx might provide insight into
the impaired angiogenic response to chronic muscle overload and hypertrophy in obesity.
It is known that angiogenic growth factors between LN and OB are no different at rest,
however, the effect on exosome biogenesis or miRNA in OB human muscle at rest or in
response to acute REx is unknown. Accordingly, the present study was designed to
investigate the hypothesis that obesity alters resting and resistance exercise-induced
expression of angiogenic growth factors, MVB biogenesis, or miRNA in human muscle.
Methods
Subjects. Sedentary, non-smoking, LN (n=8) and OB (n=8) college-aged (18-35) males
(4 LN, 4 OB) and females (4 LN, 4 OB) volunteered to participate after an explanation of
the study and informed consent approved by the University Institutional Review Board.
Sedentary was defined as participating in physical activity fewer than 20 min/d, 3 d/wk.
Subject characteristics are listed in Table 4.
Measurement of maximal oxygen (V̇O2Max) consumption.

Maximal oxygen

consumption (V̇O2Max) was measured on an electronically braked cycle ergometer (Lode,
Excaliber Sport, Groningen, Netherlands) as previously described (30). Minute ventilation
(V̇E) oxygen uptake (V̇O2), and carbon dioxide production (V̇CO2) were continuously
monitored via open circuit spirometry (True Max 2400, Parvo Medics, Salt Lake City, UT).
Heart rate (model T31, Polar Electro Inc., Woodbury, NY) and rating of perceived exertion
(RPE) were recorded at the end of each stage. The test began with a 5-min warm-up at
50W. After the warm-up, workload increased 25W every min until volitional fatigue.
Participants were verbally encouraged to continue for as long as possible. The criterion
used to assess V̇O2MAX included: 1) a heart rate above 90% of age predicted max (220 -
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age); 2) a respiratory exchange ratio greater than or equal to 1.10; and 3) identification of
a plateau (≤ 150 ml/min increase) in V̇O2 despite a further increase in workload (21). In
all tests, at least two of three criteria were met.
1-repetition maximum testing. After a 15-min rest period following the V̇O2MAX test,
one leg knee extensor (KE), one repetition maximum (1-RM) was determined in dominant
and non-dominant randomly assigned legs. An initial weight of 13.6 kg was progressively
increased by 4.5 kg until participants were unable to continue. One minute rest between
each attempt was given and the highest successfully lifted weight was designated as 1-RM.
Experimental design.

At least one week following the initial visit, participants

completed three sets of single leg REx of 8-12 repetitions at 80% of 1-RM in either the
dominant or non-dominant leg (randomly assigned). A baseline biopsy was obtained from
the non-exercise leg immediately prior to exercise, followed by biopsies in REx leg at 15
min and 3 hr post-exercise. Known VEGF responses have been observed at 2 hr and 4 hr
post-exercise for REx (15), and exosome release immediately following exercise in mice
has been identified (40), therefore, the time points of 15 min and 3 hr post-exercise were
selected. Biopsies taken from the same leg were separated by at least 3 cm (5). Samples
were stored at -80°C until analysis.
Quantitative real-time PCR. Total RNA from skeletal muscle was isolated using Trizol
reagent (Invitrogen, Carlsbad, CA). For mRNA reverse transcription, first-strand cDNA
was generated by random hexamer primers with MMLV Reverse Transcriptase
(Invitrogen). For mature miRNA reverse transcription, multiple adenosine nucleotides
were first added to the 3’ end of the total RNA with Escherichia Coli DNA polymerase
(New England BioLabs, Ipswich, MA) and cDNA was then synthesized with a Poly T
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primer including an adaptor sequence using MMLV Reverse Transcriptase. To determine
mature miRNA, the specific miRNA sequence was used as the forward primer and the
adapter sequence from the Poly T primer was used as the universal reverse primer for all
miRNAs. Real-time PCR reactions were performed with a SYBR green PCR kit in a
BioRad CFX96 Real-Time System (Bio-Rad, Hercules, CA).

Gene expression was

determined with the 2-ΔΔCt relative quantification method and was normalized to 18s for
mRNA or RNU24 for miRNA (33). Primer sequences for miRNA and mRNA are listed
in Table 5.
Muscle protein isolation and analysis. Twenty mg of frozen muscle was homogenized
in RIPA buffer (50mm Tris HCL 7.4 pH, 150mm NaCl, 2mm EDTA, 0.1% SDS, 0.1%
Triton x-100, 0.5% NaDeoxycholate) using a Bead Ruptor 12 bead homogenizer (Omni,
Kennesaw, GA). Phosphatase inhibitors (0.2 mM Na3VO4, 50 mM NaF, and a protease
inhibitor cocktail (P8340, Sigma-Aldrich, St. Louis, MO)) were added to prevent
modification of proteins post-homogenization. Total sample protein concentration was
determined by the bicinchoninic acid method (BCA protein assay kit, Bio-Rad
Laboratories, Hercules, CA).
From muscle homogenates, 30-60 µg of total protein was fractionated for Western blot
on SDS-polyacrylamide gels, transferred to a reduced-fluorescence PVDF membrane, and
incubated with one of the following antibodies: alix (#2171s, Cell Signaling Technology),
TSG-101 (#sc-7964, Santa Cruz Biotechnology), CD-63 (#sc-5275, Santa Cruz), and
thrombospondin-1 (TSP-1) (#14778, Cell Signaling).

Following primary incubation

horseradish peroxide–conjugated (#7074 Anti-Rabbit, #7076 Anti-Mouse, Cell Signaling)
secondary antibodies were incubated with the membrane and detected using florescence
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(Bio-Rad, Hercules, CA).

Densitometric analysis was performed using Image Lab

software (Bio-Rad). Results were normalized to alpha tubulin (#2144, Cell Signaling), or
ponceau S stain (P3504, Sigma Aldrich).
ELISA. Enzyme-linked immunosorbent assay (ELISA) was performed for human
VEGF (R&D, DVE00, Minneapolis, MN). Protocol from the manufacturer’s instructions
were followed and muscle homogenates were prepared at 0.25 µg/µl for a total volume of
100 µl as previously described (16). Briefly, 100 µl of each sample was analyzed and
optical density was determined using a microplate reader (Multiskan, Fisher Scientific,
Waltham, MA) at 450 nm and corrected by readings at 550 nm.
Muscle cross-section. Morphological analysis was completed as described previously
(44). Twenty mg skeletal muscle tissue was embedded in an OCT / tragacanth mixture
(~40mg tragacanth/1ml OCT) and frozen in liquid nitrogen cooled isopentane. Frozen
muscle was then cut into 10µm cross sections by using a Leica CM1850 cryostat (Leica,
Wetzlar, Germany). Frozen sections were fixed in acetone for 30 s, permeabilized and
blocked in PBS containing 5% goat serum, 3% bovine serum albumin (BSA), 0.2% Triton
X-100, and 0.1% sodium azide for 1 hr. For capillaries, mouse anti-human CD31 primary
antibody (1:1000, BD Biosciences, Franklin Lakes, NJ). Cell Membranes were identified
by staining with dystrophin (1:500; Abcam, Cambridge, MA, USA). For fiber type,
samples were directly permeabilized and blocked with blocking buffer and MyHC1 (type
1) antibody from mAB clones (American Type Culture Collection, Manassas, VA, USA).
Following primary antibody, sections were incubated with fluorescent labeled anti-IgG
secondary antibodies, goat anti-rabbit 647 for dystrophin (1:1000 Thermo Fisher Scientific,
Waltham, MA, USA), goat anti-mouse 568 for CD31(1:1000 Thermo Fisher Scientific) for
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1 hr. Fluorescent images were captured with a CoolSnap HQ charge coupled camera
(Photometrics, Tucson, AZ, USA) by using a Leica DM6000 microscope. Capillary
number was quantified using the manual count tool in Photoshop (Adobe, San Jose, CA,
USA). Fiber types were traced and recorded by immunostaining images (red for type 1,
non-stained for type 2). Fiber size was determined by the magic wand tool in Photoshop;
measurement was performed after setting the measurement scale (1 pixel= 0.57 µm; 100x
magnification) (Adobe, San Jose, CA, USA). Three subjects (1 LN, 2 OB) were excluded
from morphological analysis due to improper mounting of tissue samples at the Pre biopsy
which prevented proper staining and subsequent analysis.
The following measurements of capillarization were made: 1) the number of capillaries
around a muscle fiber, 2) capillary-to-fiber ratio, 3) capillary-to-fiber perimeter exchange
index (CFPE) and 4) capillary density.
Statistical analysis. Unpaired Student’s t-tests were used to analyze differences in
subject characteristics between LN and OB. Otherwise, a two-way mixed-plot factorial
ANOVA (group × condition) was used. Following a significant F ratio, a Fisher’s LSD
was used. Linear regression was performed to investigate relationships between variables.
Significance was established at P ≤ 0.05 for all statistical sets and data reported as Mean ±
SE. All data were analyzed using Prism Graphpad Software Version 7 (La Jolla, CA, USA)
or Microsoft Excel 2016 (Version 1708, Redmond, WA, USA).
Results
Subject characteristics. By design, body mass index (BMI) was greater in the OB
group compared to LN. OB subjects also had lower relative V̇O2Max values, and increased
fasting insulin, HOMA-IR, and triglycerides (Table 4).
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MVB biogenesis and release pathway. To determine the effect of obesity and REx on
MVB biogenesis, gene expression of ESCRT proteins was determined. A main effect for
BMI was observed for HGS and VPS4a mRNA (Figure 7). No differences were observed
for BMI with clathrin, TSG-101, alix, STAM, or VTA1. In response to REx, a trend was
observed for clathrin, with increased gene expression 3 hr compared to Pre. No other
changes were observed for ESCRT protein gene expression with REx. There was an
increase in CD63 mRNA in response to exercise at 3 hr compared to Pre and 15 min
independent of group (Figure 7).
To identify potential changes in MVB release, gene expression of Rab and syntaxin
family proteins known to be involved in MVB release were determined. There were no
changes in gene expression for Rab 11, 27A, 27B, 35 or Syntaxin1A between LN and OB
subjects at rest or in response to REx (Figure 8).
miRNA processing biogenesis. To detect the effect of obesity and REx on potential
miRNA formation, gene expression for drosha, exportin-5, and dicer were measured. No
observed differences at rest in OB subjects or in response to REx were observed for miRNA
processing (Figure 9).
Exosome surface marker protein expression. Common exosome surface markers
include alix, CD63, and TSG-101, therefore, Western blot analysis was performed for these
proteins to identify potential changes in muscle exosome content. There was no effect of
BMI for alix, TSG-101, or CD63. Changes were identified for alix and TSG-101 total
protein in response to REx, and a trend for CD-63 (Figure 10). Post-hoc analysis revealed
decreased alix protein 15 min and 3 hr post-exercise vs. Pre and 3 hr vs 15 min post-
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exercise. TSG-101 protein displayed increased protein content in response to REx at 3 hr.
The trend in CD63 showed reduced protein content 15 min vs Pre.
Skeletal muscle angiogenesis. No main effect for BMI was observed in the gene
expression of VEGF or FLK-1. VEGF gene expression was increased (~3 fold) at 3 hr
post-exercise in response to REx, with no change in FLK-1.

TSP-1, displayed an

interaction effect, with no change in LN subject’s response and increased gene expression
Pre vs. 15 min and 15 min vs. 3 hr in the OB group (Figure 11). At rest, a main effect in
the OB group is noted for miR-130a, -206, and -503 with no REx induced changes in miR126, -130a, -206, or -503 (Figure 11).
Whole muscle VEGF protein was measured via ELISA (Figure 12). There was no
change in VEGF in response to REx with a trending main effect of lower VEGF protein in
OB compared to LN.
Skeletal muscle mitochondrial regulators. Gene expression of PGC-1α and miR133a
were measured to determine mitochondrial biogenesis at rest and acute REx. There was
no effect of BMI on PGC-1α at rest, but increased expression 3 hr post-REx (~2 fold)
(Figure 13). There were no differences between groups or in response to REx for miR133a.
Muscle morphology. There was no BMI effect observed for capillary counts, capillaryto-fiber ratio, or CFPE for total, type I or type II muscle fibers (Figure 14). Capillary
density was reduced in OB type II fibers compared to LN.
Discussion
There are many differences in skeletal muscle between LN and OB individuals. In the
current report, differences between LN and OB were investigated in pathways associated
with intercellular communication at rest and following acute REx. The principal findings
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are: 1) REx increased TSP-1 mRNA only in OB; 2) lower expression of components of
MVB biogenesis and competing anti- and pro-angiogenic miRNA are present in OB; and
3) REx-induced increases in PGC-1α and VEGF mRNA were similar between groups.
Taken together, the findings provide novel insight into the effects of obesity and REx on
skeletal muscle intercellular communication pathways, which are still poorly understood
(40).
Angiogenesis and anti-angiogenic effect of REx. Global deletion of TSP-1 increases
skeletal muscle capillarization and exercise capacity in mice (34) and increased TSP-1 gene
expression is associated with increased obesity, inflammation, and insulin resistance (47).
In contrast with these data, the current investigation displays an observably low TSP-1
gene expression in OB at rest compared to lean (~70%), and a large TSP-1 response in OB
3 hr post-REx. Additionally, a trend for lower VEGF protein at rest in OB compared to
LN supports the diminished capillary density observed in the OB Type II muscle fibers.
Although both groups increased VEGF gene expression in response to REx, the increased
anti-angiogenic response in the OB group indicates a large inhibitory response to any
VEGF promoted adaptations which otherwise may have occurred in OB subjects.
MVB biogenesis altered with obesity. A fundamental role of the ESCRT machinery in
the formation of exosomes is to sort ubiquitinylated proteins (4). HGS and STAM are
shown to be involved in this process by sequestering ubiquitinylated proteins and
communicating with associated deubiquitinating proteins following sequestration (48).
The present study shows a BMI specific dysregulation of HGS and VPS4a gene expression.
Altered sorting (HGS) and degradation (VPS4a) of MVB’s may indicate an inability in the
OB group to properly sequester proteins identified for transport in exosomes. Impaired
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cellular communication is a common dysfunction associated with obesity (22), which could
include signals to remove proteins from the cell. Diminished VPS4a may be compensatory
to decreased HGS, yet underlying problems appear to exist with obesity for protein sorting.
Gene expression for exosome release (Rab family) remains intact between LN and OB
groups, demonstrating evidence that differences in protein content of exosomes could exist
in adults, as previously observed in youth (11).
Clathrin, part of the ESCRT-0 complex, trends towards increased gene expression 3 hr
post-REx, yet no alterations of the other measured ESCRT complex components occurred.
The gene expression of TSG-101 and the accessory protein alix was also unchanged,
despite altered total protein changes in response to REx. CD-63 is a known member of the
tetraspanin family associated with microvesicle release and exosome marker in other cell
types (35) and the present study showed enhanced gene expression of CD-63 3 hr postREx. Recent work demonstrated a relationship between specific exosome markers and
unique content contained therein (27).

This discovery gives insight into potential

characterization of exosome surface markers and their non-coding RNA content. Based
on this new information, conducting proteomic and transcriptomic analysis of exosomes
based on their surface marker could provide valuable information about the response to
REx in each group, such as hypertrophy or angiogenic signaling.
miRNA processing biogenesis.

Increased gene expression of miRNA processing

(drosha, exportin-5, and dicer) was identified 3 hr after an acute cycling bout (39) and data
within our lab has observed increased miRNA machinery following acute aerobic and
aerobic + REx bouts 1 hr post-exercise (data unpublished). The data displayed in the
current investigation identifies no main effect of BMI at rest for miRNA processing nor in
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response to REx. Although there is evidence to suggest that specific miRNA will increase
following acute REx (41), and REx training will alter miRNA profiles over time (6), there
was no data from the current investigation that miRNA processing in LN or OB individuals
is altered by REx for the time points selected.
Exosome surface marker protein changes. As previously identified, there is a gap in
the literature for the effects of REx alone on exosome biogenesis (40). The current
investigation identifies reduced alix protein expression 15 min post-exercise, which
remained decreased 3 hr post-exercise (Figure 10). TSG-101 protein was increased 3 hr
post-exercise. CD-63 protein shows a trend for reduced protein 15 min post-exercise.
Previously, evidence suggested peak exosome surface marker release on different days
during myotube differentiation in vitro (38), and vesicles released from myotubes are
known to halt proliferation and induce differentiation of myoblasts (13, 14). Therefore,
altered exosome surface marker expression in response to REx could indicate alternative
functions of exosomes, depending on their surface marker.
miRNA. Following a REx bout, circulating miRNA were shown to increase in human
plasma samples (41). Acute REx showed decreased expression of miR-1 in young but not
old subjects at 3 and 6 hours post-exercise, with no changes in miR-133 and -206 (8). miR133 was shown to increase immediately following REx, but returned to baseline 1 hour
post-exercise, with no change in miR-126 (46). The present investigation displayed no
changes to miR-126, -130a, -133a, -206, or -503, but exhibit a main effect of BMI for
increased expression of miR-130a, -206, and -503 (Figure 11 & 13). Capillarization is
enhanced by miR130a by blocking anti-angiogenic promoters GAX and HOXA5 (3).
Angiogenesis is decreased with miR-206 and miR-503 by impacting VEGF and NFκB
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expression (28, 43) and inhibiting the proliferative cell cycle in endothelial cells (2). Taken
together, the data shows miRNA signaling to enhance (miR-130a) and block (miR-206, 503) angiogenesis, matching the VEGF/TSP-1 signaling observed in OB subjects.
Skeletal muscle morphology and capillarization. Previously, our lab demonstrated
capillary density to be reduced in OB men compared to LN with no differences in VEGF
content (17). The diminished capillary density observed with obesity for Type II fibers
(Figure 14) displays an inherent limitation in OB subjects to respond to chronic overload
hypertrophy due to increased body mass. The anti-angiogenic response observed in the
current investigation through miRNA signals at rest and the TSP-1 response to REx
encourages the idea that a single bout of REx is not enough stimulus to overcome the
diminished capillarization observed in OB. Consistent, regular physical activity would be
required to stimulate angiogenic growth. It is unknown how many REx sessions would be
required to overcome the apparent TSP-1 response in OB, yet it is well observed that an
anti-angiogenic response represents the balance to keep capillarization in check (36).
Obesity and exosomes. Adipose derived exosomes from OB mice induce insulin
resistance in LN wild-type counterparts, demonstrating the ability of exosomes to
communicate detrimental signals in obesity (7, 22). Altered content from adipose-derived
exosomes are also observed in OB children compared to LN (11). In vitro and in vivo
models of c2c12 myotubes incubated with high palm oil, or mice fed a high fat diet,
released skeletal muscle exosomes which transferred deleterious effects on insulin
signaling (1).

As research evolves with obesity and exosome signals, it would be

recommended to identify exosome content differences which may alter metabolic signals
and impact intercellular function in adjacent tissues.
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Conclusion. Overall, altered patterns of exosome marker protein exist in response to
REx, with no changes in exosome release or miRNA processing between groups. Obesity
plays an inhibitory role in MVB production pathway gene expression, anti-angiogenic
factors, and miRNA to both inhibit and enhance angiogenesis. Future research should
focus on the content of exosomes between LN and OB subjects to determine potential
therapeutic targets in an OB population.
References
1.
2.

3.
4.
5.
6.
7.
8.

9.
10.

Aswad H, Forterre A, Wiklander OP et al. Exosomes participate in the alteration
of muscle homeostasis during lipid-induced insulin resistance in mice.
Diabetologia. 2014;57(10):2155-64.
Caporali A, Meloni M, Völlenkle C et al. Deregulation of microRNA-503
contributes to diabetes mellitus–induced impairment of endothelial function and
reparative angiogenesis after limb ischemia. Circulation.
2011:CIRCULATIONAHA. 110.952325.
Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5.
Blood. 2008;111(3):1217-26.
Colombo M, Moita C, van Niel G et al. Analysis of ESCRT functions in exosome
biogenesis, composition and secretion highlights the heterogeneity of extracellular
vesicles. J Cell Sci. 2013;126(24):5553-65.
Costill D, Pearson D, Fink W. Impaired muscle glycogen storage after muscle
biopsy. Journal of Applied Physiology. 1988;64(5):2245-8.
Davidsen PK, Gallagher IJ, Hartman JW et al. High responders to resistance
exercise training demonstrate differential regulation of skeletal muscle microRNA
expression. Journal of applied physiology. 2010;110(2):309-17.
Deng Z-b, Poliakov A, Hardy RW et al. Adipose tissue exosome-like vesicles
mediate activation of macrophage-induced insulin resistance. Diabetes.
2009;58(11):2498-505.
Drummond MJ, McCarthy JJ, Fry CS, Esser KA, Rasmussen BB. Aging
differentially affects human skeletal muscle microRNA expression at rest and
after an anabolic stimulus of resistance exercise and essential amino acids.
American Journal of Physiology-Endocrinology and Metabolism.
2008;295(6):E1333-E40.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The lancet.
2005;365(9468):1415-28.
Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer.
Nature Reviews Cancer. 2006;6(4):259-69.

50
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

21.
22.
23.
24.
25.

Ferrante SC, Nadler EP, Pillai DK et al. Adipocyte-derived exosomal miRNAs: a
novel mechanism for obesity-related disease. Pediatric research. 2014;77(3):44754.
Ferrara N. Role of vascular endothelial growth factor in regulation of
physiological angiogenesis. American Journal of Physiology-Cell Physiology.
2001;280(6):C1358-C66.
Forterre A, Jalabert A, Berger E et al. Proteomic analysis of C2C12 myoblast and
myotube exosome-like vesicles: a new paradigm for myoblast-myotube cross
talk? PLoS One. 2014;9(1):e84153.
Forterre A, Jalabert A, Chikh K et al. Myotube-derived exosomal miRNAs
downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell cycle.
2014;13(1):78-89.
Gavin T, Drew J, Kubik C, Pofahl W, Hickner R. Acute resistance exercise
increases skeletal muscle angiogenic growth factor expression. Acta physiologica.
2007;191(2):139-46.
Gavin TP, Robinson CB, Yeager RC, England JA, Nifong LW, Hickner RC.
Angiogenic growth factor response to acute systemic exercise in human skeletal
muscle. Journal of applied physiology. 2004;96(1):19-24.
Gavin TP, Stallings HW, Zwetsloot KA et al. Lower capillary density but no
difference in VEGF expression in obese vs. lean young skeletal muscle in
humans. Journal of applied physiology. 2005;98(1):315-21.
Graham T, Kahn B. Tissue-specific alterations of glucose transport and molecular
mechanisms of intertissue communication in obesity and type 2 diabetes.
Hormone and metabolic research. 2007;39(10):717-21.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity Among
Adults and Youth: United States, 2015–2016.
Hayden MR, Patel K, Habibi J et al. Attenuation of Endocrine‐Exocrine
Pancreatic Communication in Type 2 Diabetes: Pancreatic Extracellular Matrix
Ultrastructural Abnormalities. Journal of the cardiometabolic syndrome.
2008;3(4):234-43.
Howley ET, Bassett DR, Welch HG. Criteria for maximal oxygen uptake: review
and commentary. Medicine and science in sports and exercise. 1995;27(9):1292301.
Huang-Doran I, Zhang C-Y, Vidal-Puig A. Extracellular vesicles: novel mediators
of cell communication in metabolic disease. Trends in Endocrinology &
Metabolism. 2017;28(1):3-18.
Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle.
Physiological reviews. 1992;72(2):369-417.
Isenberg JS, Wink DA, Roberts DD. Thrombospondin-1 antagonizes nitric oxidestimulated vascular smooth muscle cell responses. Cardiovascular research.
2006;71(4):785-93.
Ivy JL. Role of exercise training in the prevention and treatment of insulin
resistance and non-insulin-dependent diabetes mellitus. Sports medicine.
1997;24(5):321-36.

51
26.
27.
28.

29.
30.
31.

32.
33.
34.
35.
36.
37.
38.
39.
40.
41.

Kang K, Ma R, Cai W et al. Exosomes secreted from CXCR4 overexpressing
mesenchymal stem cells promote cardioprotection via Akt signaling pathway
following myocardial infarction. Stem cells international. 2015;2015.
Kaur S, Elkahloun AG, Arakelyan A et al. CD63, MHC class 1, and CD47
identify subsets of extracellular vesicles containing distinct populations of
noncoding RNAs. Scientific reports. 2018;8(1):2577.
Keklikoglou I, Hosaka K, Bender C et al. MicroRNA-206 functions as a
pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in
pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes. Oncogene.
2015;34(37):4867.
Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and
secretion to biological function. Immunology letters. 2006;107(2):102-8.
Kraus RM, Stallings HW, 3rd, Yeager RC, Gavin TP. Circulating plasma VEGF
response to exercise in sedentary and endurance-trained men. J Appl Physiol
(1985). 2004;96(4):1445-50.
Krotkiewski M, Bylund-Fallenius AC, Holm J, Bjorntorp P, Grimby G,
Mandroukas K. Relationship between muscle morphology and metabolism in
obese women: the effects of long-term physical training. Eur J Clin Invest.
1983;13(1):5-12.
Lillioja S, Young AA, Culter CL et al. Skeletal muscle capillary density and fiber
type are possible determinants of in vivo insulin resistance in man. The Journal of
clinical investigation. 1987;80(2):415-24.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2− ΔΔCT method. methods. 2001;25(4):402-8.
Malek MH, Olfert IM. Global deletion of thrombospondin-1 increases cardiac and
skeletal muscle capillarity and exercise capacity in mice. Exp Physiol.
2009;94(6):749-60.
Nakamura K, Jinnin M, Harada M et al. Altered expression of CD63 and
exosomes in scleroderma dermal fibroblasts. Journal of dermatological science.
2016;84(1):30-9.
Olfert IM, Birot O. Importance of anti‐angiogenic factors in the regulation of
skeletal muscle angiogenesis. Microcirculation. 2011;18(4):316-30.
Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a
secretory organ. Nature Reviews Endocrinology. 2012;8:457.
Romancino DP, Paterniti G, Campos Y et al. Identification and characterization of
the nano‐sized vesicles released by muscle cells. FEBS letters. 2013;587(9):137984.
Russell AP, Lamon S, Boon H et al. Regulation of miRNAs in human skeletal
muscle following acute endurance exercise and short‐term endurance training.
The Journal of physiology. 2013;591(18):4637-53.
Safdar A, Saleem A, Tarnopolsky MA. The potential of endurance exercisederived exosomes to treat metabolic diseases. Nat Rev Endocrinol.
2016;12(9):504-17.
Sawada S, Kon M, Wada S, Ushida T, Suzuki K, Akimoto T. Profiling of
circulating microRNAs after a bout of acute resistance exercise in humans. PloS
one. 2013;8(7):e70823.

52
42.
43.
44.
45.
46.
47.
48.
49.
50.

Simoneau J, Colberg S, Thaete FL, Kelley D. Skeletal muscle glycolytic and
oxidative enzyme capacities are determinants of insulin sensitivity and muscle
composition in obese women. The FASEB Journal. 1995;9(2):273-8.
Stahlhut C, Suárez Y, Lu J, Mishima Y, Giraldez AJ. miR-1 and miR-206
regulate angiogenesis by modulating VegfA expression in zebrafish.
Development. 2012;139(23):4356-65.
Sullivan B. Effects of Obesity and Resistance Exercise on the Regulation of
Skeletal Muscle Fiber Size. Purdue University; 2017.
Tang K, Breen EC, Gerber H-P, Ferrara NM, Wagner PD. Capillary regression in
vascular endothelial growth factor-deficient skeletal muscle. Physiological
genomics. 2004;18(1):63-9.
Uhlemann M, Möbius-Winkler S, Fikenzer S et al. Circulating microRNA-126
increases after different forms of endurance exercise in healthy adults. European
journal of preventive cardiology. 2014;21(4):484-91.
Varma V, Yao-Borengasser A, Bodles AM et al. Thrombospondin-1 is an
adipokine associated with obesity, adipose inflammation, and insulin resistance.
Diabetes. 2008;57(2):432-9.
Wright MH, Berlin I, Nash PD. Regulation of endocytic sorting by ESCRT–
DUB-mediated deubiquitination. Cell biochemistry and biophysics. 2011;60(12):39-46.
Zhou B, Ma R, Si W et al. MicroRNA-503 targets FGF2 and VEGFA and inhibits
tumor angiogenesis and growth. Cancer letters. 2013;333(2):159-69.
Ziche M, Morbidelli L. Nitric oxide and angiogenesis. Journal of neuro-oncology.
2000;50(1-2):139-48.

53

Table 4. Subject Characteristics. BMI, body mass index; V̇o2MAX,
maximal oxygen consumption; KE, maximal knee extensor strength;
HOMA-IR, homeostasis model assessment – insulin resistance; HOMA-β,
homeostatic model assessment – cell function; HDL, high density
lipoprotein; LDL, low density lipoprotein. Mean ± SE. N = 8 LN, N = 8
OB. *p≤0.05

LN

OB

Age, y

21.5 ± 0.5

24.8 ± 1.6

Height, m

1.7 ± 0.03

1.73 ± 0.03

Mass, kg

62.4 ± 2.0

109.9 ± 7.8*

BMI, kg/m2

21.7 ± 0.8

36.6 ± 1.8*

̇ 2MAX, L×min-1
Vo

2.34 ± 0.2

2.84 ± 0.26

V̇o2MAX, ml×kg-1×min-1

37.3 ± 2.7

26.1 ± 2.7*

1-RM, kg

27.8 ± 0.7

40.3 ± 4.7*

1-RM, kg/kg

0.45 ± 0.01

0.37 ± 0.04

Fasting Glucose, mg/dl

86.1 ± 4.8

89.0 ± 4.9

Fasting Insulin, μIU/ml

11.8 ± 1.3

28.3 ± 4.8*

HOMA-IR

2.46 ± 0.29

6.38 ± 1.23*

Total Cholesterol, mg/dl

162.8 ± 12.3

180.6 ± 6.0

HDL, mg/dl

58.4 ± 7.3

42.9 ± 5.4

LDL, mg/dl

88.6 ± 12.8

108.6 ± 5.2

Triglycerides, mg/dl

79.4 ± 7.7

131.6 ± 22.5*
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Table 5. Gene sequences of mRNA and miRNA, obtained from the Harvard Primer Bank.
Apoptotic linked gene-2 interacting protein X (Alix); Tumor Susceptibility Gene-101
(TSG-101); hepatocyte growth factor-regulated tyrosine kinase substrate (HGS); signal
transducing adaptor molecule (STAM); vesicle trafficking 1 (Vta1); vacuolar protein
sorting mutant (Vps4a).
Gene

Forward (5’-3’)

Reverse (5’-3’)

Alix
Clathrin
TSG-101
CD63
Dicer
Exportin-5
Drosha
HGS
STAM
VTA1
Vps4a
Rab11A
Rab27A
RAB27B
RAB35
Syntaxin
1A

ATGGCGACATTCATCTCGGTG
ATTCTGCCAATTCGTTTTCAGGA
GAGAGCCAGCTCAAGAAAATGG
CAGTGGTCATCATCGCAGTG
GAGCTGTCCTATCAGATCAGGG
ATCCTGGAACACGTTGTCAAG
TGTCACAGAATGTCGTTCCAC
CTCCTGTTGGAGACAGATTGGG
AATCCCTTCGATCAGGATGTTGA
CTCCCCGCACAGTTCAAGAG
CCACGCTATCAAGTATGAGGC
CAACAAGAAGCATCCAGGTTGA
GCTTTGGGAGACTCTGGTGTA
TAGACTTTCGGGAAAAACGTGTG
TACTGTTGCGTTTTGCAGACA
CGAGACCGCTTCATGGATGAG

CGCTTGGGTAAGTCTGCTGG
GCTTTCAGTGCAATTACTTTGCT
TGAGGTTCATTAGTTCCCTGGA
ATCGAAGCAGTGTGGTTGTTT
ACTTGTTGAGCAACCTGGTTT
CACTACAATTCGAGACAGAGCAT
GGGCCTAAAGGATGGTGCT
GTGTGGGTTCTTGTCGTTGAC
CGAGACTGACCAACTTTATCACA
AACGACAGTAATAAGCCACCAC
CCGTGTTTCTCTTTGCTTCGTA
GCACCTACAGCTCCACGATAAT
TCAATGCCCACTGTTGTGATAAA
AGAAGCTCTGTTGACTGGTGA
CCCCGATAATACGTGGAGGTG
ACTTGGAACGAACTTTGTTTGC

miR-126
miR-130a
miR-133a
miR-206
miR-503

TCGTACCGTGAGTAATAATGCG
CAGTGCAATGTTAAAAGGGCAT
TTTGGTCCCCTTCAACCAGCTG
TGGAATGTAAGGAAGTGTGTGG
TAGCAGCGGGAACAGTTCTGCAG
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Figure 7. Gene expression analysis of MVB biogenesis/ESCRT in response to REx
for LN (black) and OB (gray) subjects (n=8 each group). ESCRT-0 proteins
hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) (A) and clathrin
(B), ESCRT-I proteins Tumor Susceptibility Gene-101 (TSG-101) (C), Apoptotic
linked gene-2 interacting protein X (Alix) (D), ESCRT- III proteins signal
transducing adaptor molecule (STAM) (E), vesicle trafficking 1 (Vta1) (F), vacuolar
protein sorting mutant (Vps4a) (G), and a known exosome surface marker, CD- 63
(H). *p≤0.05 vs Pre; #p≤0.05 vs 15 min. Data are presented as Mean ± SE.

56

Figure 8. Gene expression analysis of MVB/exosome release for LN (black) and OB (gray)
subjects (n=8 each group). Rab and syntaxin family proteins are associated with MVB
fusion with the membrane, leading to exosome release. Data are presented as Mean ± SE.
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Figure 9. Gene Expression analysis of miRNA processing pathway drosha (A), exportin5 (B), and dicer (C) for LN (black) and OB (gray) subjects (n=8 each group). Data are
presented as Mean ± SE.
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Figure 10. Western blot analysis of exosome surface markers for Alix (A), TSG-101 (B),
and CD63 (C). LN (black) and OB (gray) subjects (n=8 each group). *p≤0.05 vs Pre,
#p≤0.05 vs 15 min. Data are presented as Mean ± SE.
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Figure 11. Gene expression analysis of angiogenic factors VEGF, TSP-1, FLK-1 and
miRNA. LN (black) and OB (gray) subjects (n=8 each group). *p≤0.05 vs. Pre,
#p≤0.05 vs 15 min. Data are presented as Mean ± SE.
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Figure 12. Vascular endothelial growth factor (VEGF) ELISA measuring total VEGF in
skeletal muscle homogenates isolated in RIPA buffer. LN (Black) and OB (Gray)
subjects (n=8 each group) are shown. Data are presented as Mean ± SE.
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Figure 13. Gene expression analysis of mitochondrial factors PGC-1α and miR- 133a. LN (black)
and OB (gray) subjects (n=8 each group). *p≤0.05 vs. Pre, #p≤0.05 vs 15 min. Data are presented
as Mean ± SE.
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Figure 14. Muscle capillarization determined between LN (black) (n=7) and OB (gray)
(n=6) subjects. Data displays capillary contacts (A), capillary-to- fiber ratio (B), capillary
density (C), and capillary-to-fiber perimeter exchange index (CFPE) (D). Data are
presented as Mean ± SE.
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Abstract
Introduction: Multivesicular bodies (MVB’s) have generated interest in understanding
intercellular communication.

MVB’s bud internally to form exosomes, which have

potential for organ cross-talk once released. Limited data suggests exosomes are released
from skeletal muscle in response to exercise. The role of skeletal muscle with exosome
signaling is not well understood. Calcium is known to be involved with exosome release
in other tissues, and since skeletal muscle is highly regulated by calcium signaling during
muscle contraction, it is a likely pathway. One candidate is calcium-calmodulin kinase II
(CaMKII), known to release other small vesicles upon activation.

Electrical pulse

stimulation (EPS) is an in vitro approach to activate differentiated skeletal muscle
myotubes. We hypothesized that skeletal muscle will release exosomes, controlled in part
through CaMKII, in response to EPS.
Methods: Skeletal muscle biopsies were obtained from lean, healthy, male collegeaged subjects (n=8) and satellite cells isolated for use in cell culture (SkMCC). To ensure
proper differentiation, SkMCC had markers pax7, Myogenin (MyoG), and myosin heavy
chain (MHC) measured via Western blot on day’s 0, 2, 4, 6, and 8 in a subset of cells.
SkMCC were stimulated for 30 min with EPS to validate activation of in vivo exercise
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pathways adenosine monophosphate kinase (AMPK), mitogen activated protein kinase
(MAPK) and CaMKII. SkMCC underwent 24 h of EPS with and without the addition of
KN-93, a chemical inhibitor of CaMKII. Quantification of isolated exosomes following
EPS was accomplished by use of a NanoSight, rt-PCR, and Western blot analysis.
Results: Day 8 compared to day 6 appeared to be the ideal day for differentiation with
respect to MHC protein and formation of myotubes. No differences were observed with
EPS or CaMKII inhibition to alter MVB biogenesis, release, or miRNA processing
pathways. There was a marked reduction of nanoparticles observed in response to EPS
compared to control.
Discussion: The main finding of the current investigation was despite an identifiable
change in MHC and formation of myotubes, there appears to have been minimized
contractile activity in vitro leading to activation of metabolic pathways and MVB release.
Strong trends for the phosphorylation of AMPK and clathrin gene expression, reduced gene
expression of PDK4, and reduced total nanoparticles in response to EPS indicate that
changes occurred, though not to the anticipated levels based on preliminary data.
Introduction
Skeletal muscle (SkM) contributes 40% of daily energy expenditure (58). As SkM is
activated, myokines are released and act in paracrine or endocrine-like fashion to regulate
targeted tissues (38). Aerobic exercise is a known stimulus to release myokines through
contraction (38, 39). Coupled with SkM contraction is adequate calcium release from the
sarcoplasmic reticulum, which leads to activation of several intracellular signaling
pathways, including calcium-calmodulin kinase II (CaMKII) (1, 43, 44).
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Another method for cell-to-cell communication is via exosomes, small vesicles (30100nm) released by tissues such as mast and epithelial cells (29). These vesicles contain
proteins, mRNA and miRNA which can regulate target tissues. For example, skeletal
muscle myotube derived exosomes decrease myoblast proliferation by downregulating the
cell cycle protein cyclin D and increase myoblast differentiation by upregulating the
muscle development and repair protein myogenin (15, 16). This identifies exosomes as a
potential source of paracrine signaling.
Exosome biogenesis occurs from the internal budding of multivesicular bodies (MVB)
via four protein complexes called the endosomal sorting complex required for transport
(ESCRT) (0, I, II, III) (12). ESCRT-0 recognizes and sequesters ubiquitinylated proteins
and associates with several accessory proteins, including signal transducing adaptor
molecule (STAM), hepatocyte growth factor-regulated tyrosine kinase substrate (HGS),
and tumor susceptibility gene 101 (TSG-101) (12, 53). As part of the ESCRT-I complex,
TSG-101 recruits either the apoptotic linked gene-2 interacting protein X (alix) or the
ESCRT-II complex (12, 25, 52). Alix or ESCRT-II will then recruit ESCRT-III, which is
primarily responsible for scission of the MVB within the cell membrane (57) resulting in
MVB fusion with the plasma membrane and exosome release (8, 25). MVB’s not fused
with the cell are degraded by a trafficking protein, vacuolar protein sorting mutant (Vps4a,
Vps4b) (5).
Exosome release from the cell is a coordinated and well-documented process (4, 21,
42). Exosome release occurs through MVB fusion to the plasma membrane through
soluble NSF attachment protein receptor complexes (SNARE) (4). Rab proteins are known
to regulate SNARE protein function through direct or indirect contact (10, 24). Specific
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members of the Rab and syntaxin family identified with exosome regulation include
Rab11, 27a, 27b, 35, and Syntaxin 1A (4, 37). Increased expression of these factors
indicate increased activity at the endosome, the location of MVB biogenesis (25, 37).
Exosome release can be regulated by multiple intracellular signals including altered
pH, hypoxia, and oxidative stress, all of which are increased in response to exercise (42).
Exosome release is increased via calcium signaling in mast cells and cortical neurons (54)
as well as K-562 cells (47). Given that exercise-induced motor neuron activity leads to
increases in intracellular calcium and myofiber contraction, calcium activated pathways
may be important in regulating skeletal muscle exosome release.

Exercise-induced

activation of CaMKII has been implicated in muscle contraction (9, 49).

CaMKII

activation also regulates maristoylated alanine-rich C-kinase substrate (MARCKS), a
membrane binding protein associated with vesicles ~100 nm in diameter (2).

This

association of CaMKII with membrane bound vesicles and skeletal muscle contraction
make it a possible regulator for skeletal muscle exosomes.
In vivo treadmill and cycling exercise have been shown to release extracellular vesicles
into the circulation, but the specific tissue of origin could not be determined (18). Using
an in vitro modeling system allows the capture of vesicles released exclusively from
skeletal muscle. Several attempts to identify skeletal muscle exosome “cross-talk” with
other tissues has been accomplished in mice (3, 55) and C2C12 cell lines (15, 16). The
regulation of SkM exosome release, particularly in human muscle, is poorly understood
(34). As electrical pulse stimulation (EPS) has been used to induce muscle contraction of
differentiated myotubes (33, 48), there is a potential to utilize EPS to enhance exosome
release, which to our knowledge has not been accomplished. It was hypothesized that EPS
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will stimulate the biogenesis and release of exosomes from skeletal muscle, moderated in
part through CaMKII.
Methods
A multi-step approach was used to identify changes in MVB biogenesis and release in
response to EPS. First, tube formation was optimized to ensure adequate growth and
differentiation of primary human myoblasts into myotubes. Second, the phosphorylation
of common exercise-stimulated pathways (adenosine monophosphate kinase (AMPK),
mitogen activated protein kinase (MAPK), and CaMKII) in response to EPS provided
validation of EPS use as an exercise mimetic. Third, myotubes were electrically stimulated
for 24 hours with and without a CaMKII inhibitor to investigate regulation of exosome
release.
Subjects. Subject characteristics are provided in Table 6. Lean, healthy, young (18-35
y) male subjects (n=8) volunteered for the study following informed consent approved by
the University Institutional Review Board.

Subjects underwent V̇O2Max testing to

characterize aerobic capacity. At least one week later, SkM biopsies from the vastus
lateralis and blood draws were obtained following a 12 h fast. Sample size was calculated
using a power analysis (α= 0.05, β= 0.80) from pilot work showing increased alix protein
in the media from control (1.0 AU) compared to EPS (2.9 ± 1.3 AU).
Cell culture procedures. Myoblasts were isolated as previously described (7, 23).
Briefly, SkM biopsies were minced and pre-plated on non-collagen coated plates for 3 h at
37˚C and 5% CO2 to remove fibroblasts, then transferred to collagen coated plates with
media changed every other day until confluence. Following isolation, myoblasts were
sorted using Micro Bead CD-56+ antibody (Miltenyi Biotec, Auburn, CA). Samples were
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grown to confluence and transferred to six separate 6-well dishes at passage 4 beginning
with approximately 75,000 cells/well.
Experimental Design. Study 1. For samples to be successfully electrically stimulated,
it is essential to have myoblasts differentiate to myotubes as only myotubes express myosin
heavy chain (MHC) myofilaments. Previous protocols established for differentiation of
myotubes were followed (20, 31). In brief, myoblasts were grown in SkM growth media
(Lonza, Basel Switzerland) to approximately 85-90% confluence on a 6-well plate,
followed by serum-deprivation (2% Horse Serum in Dulbecco’s Modified Eagle Medium
(DMEM) (ThermoFisher, Waltham, MA)). Protein was collected on day’s 0, 2, 4, 6, and
8 to determine the progression of muscle differentiation markers pax7, MyoD, myogenin
and MHC via western blot (6).
Immunostaining was performed to identify fusion index (FI) of myotubes on day 6 and
day 8. For each sample analyzed (n=3), cells were washed 3X with phosphate buffered
saline (PBS), fixed with 4% paraformaldehyde for 5 min at room temperature, and washed
again 3X with PBS. Cells were incubated with 100 mM glycine for 15 min, washed 3X
with PBS, then incubated with blocking buffer (5% goat serum+2% BSA+ 0.2% Triton X100 and 0.1% Sodium Azide in PBS) for 1-2 hours. Primary antibody was diluted in
blocking buffer at 4oC overnight with MF-20 at 1:1000 dilution (R&D, Minneapolis, MN).
Secondary antibody (Alex568 IgG1, anti-mouse; Cell Signaling Technologies) and DAPI
for nuclei (Cell Signaling Technologies) at 1:1000 dilution were incubated in PBS for 1
hour, then visualized by fluorescent microscopy. Myotubes which contained at least 2
nuclei were counted and FI was the total number of nuclei incorporated into MHC +
myotubes divided by the total number of nuclei in the field of view.
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Study 2.

To establish activation of known in vivo exercise-induced metabolic

pathways, myotubes underwent control (exposure to stimulation plate without EPS
activated) or EPS stimulation for 30 min at 14 V, 1 Hz, and 1 ms bursts. This intensity was
determined from unpublished data in our lab using C2C12 cells to activate metabolic
pathways, such as AMPK and matches protocols used in primary human SkM cultures
(34). Exercise-stimulated pathways shown in vivo related to calcium signaling include
CaMKII (1, 43, 44), AMPK (41), and MAPK (26). Following 30 min, cultures were
washed with 1x PBS, collected in 100 µl RIPA buffer per well and used to identify
phosphorylation changes of CaMKII, AMPK, and P-38 MAPK via western blot analysis.
Combes et al. recently showed that immediately after 30 min of cycling exercise, SkM
CaMKII, P38 MAPK, and AMPK were phosphorylated in vivo (13). A design of each
plate is displayed in Figure 15.
Study 3. On Day 8 (determined in Study 1), media was changed from 2% HS DMEM
to 10% exosome-free fetal bovine serum (FBS) DMEM for EPS. FBS was made exosome
free via ultracentrifugation (47). Stock solution of FBS was centrifuged at 800 × g for 10
min to remove sediment, then centrifuged at 12,000 × g for 30 min to remove cellular
debris. Exosomes were further isolated from the supernatant by centrifuging at 100,000 ×
g for 2 hours and removed.
The control condition was exposure to stimulation plate without EPS activation. EPS
samples were stimulated for 24 h at 14 V, 1 Hz, 1 ms bursts, to allow an accumulation of
exosomes in the media. In addition, KN-93, a chemical inhibitor of CaMKII, and KN-92
(Sigma-Aldrich, St. Louis, MO, USA), a negative control for KN-93, were added in control
and EPS conditions. In total, six conditions were tested in duplicate: control (non-
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stimulated) and EPS (stimulated), each with the following additions: 10 µM KN-92, 10
µM KN-93, and an equivalent volume of solvent (ddH2O) (Figure 15). Chemicals were
added in 10 µM concentration, shown previously to effectively inhibit CaMKII activity in
rat myotubes (36, 50). Following 24 h, SkM cells were collected in RIPA buffer (100µl
per well, 50mm Tris HCL 7.4 pH, 150mm NaCl, 2mm EDTA, 0.1% SDS, 0.1% Triton x100, 0.5% NaDeoxycholate) for Western blot analysis and Trizol (500µl per well) for RNA
analysis via rt-PCR. Phosphatase inhibitors (0.2 mM Na 3VO4, 50 mM NaF, and a protease
inhibitor cocktail (P8340, Sigma-Aldrich, St. Louis, MO)) were added to prevent
modification of proteins. Total sample protein concentration was determined by the
bicinchoninic acid method (BCA protein assay kit, Bio-Rad Laboratories, Hercules, CA).
Primary outcomes identified were exosome biogenesis (STAM, HGS, TSG-101, clathrin,
VSP4a), exosome release (Rab11, 27a, 27b, 35, and Syntaxin 1A), and exosome surface
markers (Alix, TSG-101, CD-63).
Exosome isolation. Previous pilot data from our laboratory identified that cell culture
samples measured in triplicate from the same initial number of cells produced equivalent
protein and mRNA values upon isolation in RIPA or Trizol. The coefficient of variation
was 7.8% for protein concentration (µg/µl) and 11.7% for RNA concentration (ng/µl). To
attain adequate volume of media for exosome isolation, media was combined from
individual wells in each condition. Per manufacturer’s instructions, media was centrifuged
at 3000 × g for 15 min to remove cellular debris and filtered with a 0.22 µm filter (Fisher
Scientific, Waltham, MA) to remove large particles and additional cellular debris (3). To
isolate exosomes, 4 ml of media was inverted several times in a 5X dilution of ExoQuickTissue Culture solution (System Biosciences, Palo Alto, CA, USA) for at least 12 hours at
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4˚C. Following incubation, media was centrifuged at 5000 × g for 30 min, supernatant
removed, then centrifuged at 5000 × g for 5 min. Remaining media was carefully aspirated
with exosome pellet re-suspended in RIPA buffer for western blot analysis of exosome
markers.
Quantitative real-time PCR. Total RNA from SkM was isolated using Trizol reagent
(Invitrogen, Carlsbad, CA). For mRNA reverse transcription, first-strand cDNA was
generated by random hexamer primers with MMLV Reverse Transcriptase (Invitrogen).
Real-time PCR reactions were performed with a SYBR green PCR kit in a BioRad CFX96
Real-Time System (Bio-Rad, Hercules, CA). Gene expression was determined with the 2 ΔΔCt

relative quantification method and was normalized to 18s. Primer sequences are listed

in Table 7.
Skeletal muscle protein analysis. From cell culture isolations, 20-40 µg of total protein
was fractionated for Western blot on SDS-polyacrylamide gels, transferred to a reducedfluorescence PVDF membrane, and incubated with one of the following antibodies: alix
(#2171s, Cell Signaling Technology), TSG-101 (#sc-7964, Santa Cruz Biotechnology),
CD-63 (#sc-5275, Santa Cruz), CaMKII phospho (#12716, Cell Signaling) and pan (#3362,
Cell Signaling), P38 MAPK phospho (#4511, Cell Signaling) and pan (#9512S, Cell
Signaling), and AMPK phospho (#2532S, Cell Signaling) and pan (#2535S, Cell
Signaling). Following primary incubation horseradish peroxide–conjugated (#7074 AntiRabbit, #7076 Anti-Mouse, Cell Signaling) secondary antibodies were incubated with the
membrane and detected using florescence (Bio-Rad, Hercules, CA).

Densitometric

analysis was performed using Image Lab software (Bio-Rad). Results were normalized to
alpha tubulin (#2144, Cell Signaling), or ponceau S stain (P3504, Sigma Aldrich).
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Exosome quantification. For quantification of total exosomes released following EPS
compared to control, exosome pellets from 1 ml of media were isolated using a 5X ExoQuick solution, then resuspended in 300 µl PBS for quantification using the NanoSight
LM10 (Malvern Panalytical, Malvern, UK).

NanoSight has been demonstrated to

effectively identify exosome-sized vesicles from blood plasma (28).

Samples were

automatically analyzed in triplicate using 60 s video clips by NanoSight tracking software
using Brownian motion analysis (14).
Statistical analysis.

For fusion index, differentiation markers, and preliminary

exosome isolation, a paired Student’s t-test was used. Otherwise, a two-way mixed-plot
factorial ANOVA (group × condition) was used. Following a significant F ratio, a Fisher’s
LSD was used. Significance was established at P ≤ 0.05 for all statistical sets and data
reported as Mean ± SE. All data were analyzed using Prism Graphpad Software Version
7 (La Jolla, CA, USA) or Microsoft Excel 2016 (Version 1708, Redmond, WA, USA).
Results
Study 1. SkM differentiation. In a subset of samples (n=3), Western blot analysis
identified increased MHC ~60% in day 8 compared to day 6 (Figure 16). Day 2 and day 4
had reduced MHC protein compared to day 6 and day 8. Gene expression displayed no
differences between Pax3, Pax7, MyoG, and MHC between day 6 and day 8 (Table 8).
SkM cultures stained for FI (n=2) visibly displayed increased myotube formation and
incorporated nuclei, with multi-nucleated muscle fibers in day 8 compared to day 6 (Figure
17).
Study 2. Experimental control between ddH2O and KN-92. To ensure no differences
existed between control or EPS conditions with the addition of KN-92, an equal volume of
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solvent (ddH2O) was added to each plate as an experimental control. There were no
differences detected for any gene expression or whole protein data analyzed by t-test
between control (ddH2O) and control (KN-92) nor in EPS (ddH2O) and EPS (KN-92).
Therefore, all data presented in the present investigation will be KN-92 and KN-93 with
control (non-EPS) and EPS conditions.
Phosphorylation of in vivo pathways were not observed. There were no observed
changes in phospho/pan ratio’s in P38 MAPK or AMPK (Figure 18). There was a trend
for an interaction effect in CaMKII phospho/pan ratio, with ~40% increased ratio in the
KN-93 treatment from Control to EPS.
Study 3. MVB biogenesis and release pathway. There were no observed changes in
MVB biogenesis pathway HGS, TSG-101, Alix, STAM, VTA1, or VPS4a, or in the
exosome marker CD63 (Figure 19). However, a trending interaction for clathrin gene
expression was observed in response to EPS, which displayed a ~20% decrease with KN92 and ~20% increase with KN-93.
To determine MVB release, Rab and Syntaxin family gene expression was analyzed.
There were no observed changes to Rab11A, 27A, 35, or Syntaxin1A (Figure 20). There
was a trend for a main effect of CaMKII inhibition to increase Rab27B gene expression,
with ~40% increase in control and ~15% increase in EPS conditions.
To determine the effect of EPS on miRNA processing, gene expression for proteins in
the production of miRNA were measured. There were no differences in drosha, exportin5, or dicer in response to EPS or CaMKII inhibition (Figure 21).
Exosome quantification and surface marker identification. To determine quantity
changes, exosomes were isolated from the media for analysis as well as protein and gene
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expression analysis from cell cultures. Protein isolated from cell culture for CD63 and alix
remained unchanged in response to EPS or CaMKII inhibition. A notable trend with
CaMKII inhibition was observed with TSG-101 and clathrin total protein, with increased
expression in KN-93 for TSG-101 and diminished expression of proteins with KN-93 for
clathrin (Figure 22).
No differences were observed for TSG-101 or alix when exosomes were isolated from
media (Figure 22). A strong trend for CD63 with CaMKII inhibition was observed with
~30-40% increased expression in KN-93 compared to KN-92.
NanoSight tracking technology was used to determine quantity of nanoparticles
detected from an isolation of exosomes from media in Control and EPS samples without
CaMKII inhibition. EPS was shown to have decreased total quantity of nanoparticles 0200 nm in size compared to control (Table 9). There was a ~30% reduction in total particle
number with EPS in both the 151.5-175.5 nm and 176.5-200.5 nm ranges.
In vivo pathway expression differences. To further determine the effectiveness of EPS,
gene expression analysis for well-known in vivo markers of muscle contraction were
analyzed. A decreased expression of PDK4 was observed with CaMKII inhibition, with a
trend for diminished IL-6 gene expression (Figure 23). No differences were observed in
VEGF or PGC-1α in response to EPS or KN-93.
Discussion
The main overall finding of the current investigation were changes in MHC protein at
day 8 compared to day 6 of differentiation, observed trends for the phosphorylation of
AMPK, increased clathrin gene expression, reduced PDK4 gene expression, and reduced
total nanoparticles in response to EPS. It is difficult to assess myotube contraction during
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EPS, and despite identifiable MHC expression and apparent formation of myotubes,
minimal contractile activity occurred compared to the anticipated preliminary data analysis
previously observed with exosome surface marker changes.
In vivo phosphorylation events. As mentioned previously, evidence in vivo suggests
30 min of cycling sufficiently activates the phosphorylation of AMPK, CaMKII, and P38
MAPK (13). Without the ability to verify the total number of myotubes which contracted
during EPS, it was not possible to determine a relative “intensity” in vitro. During in vivo
exercise, the total number of muscle fibers recruited must be rigorous enough to stimulate
metabolic pathways. A decrease in ATP to form AMP will stimulate AMPK (17). CaMKII
is an upstream target of AMPK, and therefore, the decreased expression of AMPK in KN93 samples may be an indication that the CaMKII inhibition was effective in the cells. The
observed trend for an interaction effect with phospho/pan CaMKII could be explained by
the fact that KN-93 uses competitive inhibition to block CaMKII activity, so
phosphorylation still occurs with less downstream targets available (50).
MVB biogenesis, release, and miRNA processing. The interaction effect observed with
clathrin gene expression gives insight to the importance of ESCRT-0 and CaMKII.
Although other changes downstream of clathrin are not observed, it establishes a targeted
approach for future study designs with MVB biogenesis and CaMKII interactions. The
same relationship exists with MVB release as indicated by the effect of CaMKII inhibition
with Rab27B. For both clathrin and Rab 27B, the inhibition of CaMKII increased their
overall gene expression, suggesting CaMKII plays an inhibitory role at rest on these genes.
miRNA processing has been shown to be regulated by in vivo exercise (45). Data from
our laboratory has also identified changes to miRNA processing drosha, exportin-5, and
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dicer following aerobic exercise (unpublished data). The present investigation displayed
no alterations with miRNA processing in response to EPS or CaMKII inhibition. Although
calcium signaling plays a critical role in MVB release, it appears to have no effect on MVB
content. If calcium signaling was involved, a reduction in miRNA processing should have
been observed in non-stimulated controls at rest and diminished gene expression following
EPS.
Exosome quantification and surface marker changes. Previous research has identified
that extracellular vesicles released from C2C12 myotubes inhibit proliferation of myoblasts
(15). With known interactions from myotubes to inhibit myoblasts through exosome
signaling, a possible explanation to the reduced exosome number from the NanoSight and
reduced total protein trends in the media following EPS may be explained to stimulate the
proliferation of myoblasts.

If skeletal muscle exosomes also diminish myoblast

proliferation, then a reduced number of exosomes would allow myoblast proliferation to
increase.
In vivo aerobic exercise pathway response and myotube contraction. CaMKII is
known to be involved with Glut 4 transporters (35), so activation of glycolytic factors such
as PDK4 would be critically important to meet energy demands with activity. A perplexing
situation with the current investigation is the apparent lack of myotube contraction in
response to EPS, observed by unaltered PDK4, VEGF and PGC-1α gene expression.
Moreover, CaMKII inhibition reduced PDK4 gene expression.
A potential problem with calcium signaling (and therefore myotube contraction) was
the use of streptomycin as an antibiotic in the culture media. This antibiotic has a known
interaction to block intracellular calcium signaling, which could block the effect of calcium
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release leading to myotube contractions (40). However, we have successfully completed
EPS studies within our laboratory in the past in human and C2C12 myotubes (preliminary
data used to calculate sample size for the present study) and other investigations commonly
use antibiotics in EPS with valid results (23). A likely deterrent to myotube contraction in
response to EPS is poorly differentiated tubes, as previously identified (19). An analysis
of mRNA content from rt-PCR displays three of the eight subjects had 3-4 cq’s lower MHC
gene expression, despite optimization of the 8th day of differentiation. A 4 cq difference
results in a 16-fold reduction of MHC between subjects and was a likely source of
diminished myotube formation and contraction.
Alternative Hypothesis
Calcium release in SkM cells is critically important. Calcium release directly, but not
via CaMKII activation, may also be a plausible cause of exosome release as has been shown
in other tissue (47, 54). To fully elucidate this potential mechanism, enhanced and
inhibited calcium release should also be explored in conjunction with EPS. Other calcium
signaling pathways include Protein Kinase C with a calcium binding domain for activation
(32), linked to MARCK activation along with CaMKII in skeletal muscle (22).
Identification of specific miRNA could play a role in furthering our understanding of
the many pathways in response to CaMKII inhibition and EPS. Previous work has
demonstrated that miR-107 enhances PDK4 activity (56). miR-107 is also known to
increase in mice following exercise (46). Increased miR-107 would indicate an increased
metabolic demand, indicating EPS in the cells was effective.
Increased oxidative stress induced through incubation of IL-4 in B cells obtained from
mice increased exosome release (30). If oxidative stress were induced through EPS, one
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potential mechanism to increase vesicle release is the phosphorylation of P38 MAPK,
shown to increase endocytosis through a guanylnucleotide dissociation inhibitor (GDI)Rab5 complex (11). Further analysis of oxidative stress need to be explored to determine
this potential mechanism.
Limitations
A KN-93 concentration of 10 µM has been identified to reduce CaMKII activity in rat
myotubes, but not properly established in human muscle cells. Ideally, a dose-response
should be established with primary human cells to determine an effective inhibition. To
combat this, downstream targets of CaMKII would also need to be explored to determine
the effectiveness of inhibition, such as Glut-4 expression (35) or cAMP response element
binding protein (51).
Although calcium could be an important regulator of exosome release, there was no
measure of the total amount of calcium in vitro. To explore the effect of intracellular
calcium on exosome biogenesis and release independent of EPS, it would be prudent to
stimulate calcium using an ionophore such as A-23187 (27). Stimulation of calcium
release without EPS would help to determine the full effect of EPS conditions compared
to calcium alone.
Conclusion
The future direction of human SkM exosomes isolated in vitro will enable treatment of
other cellular environments to determine “cross talk” potential. To our knowledge, primary
human SkM exosomes have not been used to identify changes in other cells types (3, 34).
One therapeutic target of interest is endothelial cells (EC). Preliminary data from our lab
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has shown enhanced proliferation and migration of EC’s in response to treatment with
exosomes isolated from C2C12 SkM cultures. Other potential targets related to exosomes
isolated from EPS would be cardiomyocytes, hepatocytes, and alveolar cells. The heart,
liver, and lungs receive a large amount of blood during aerobic exercise, making them ideal
locations for SkM exosomes to interact in vivo.
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Table 6. Subject characteristics. BMI, body mass index; V̇o2MAX,
maximal oxygen consumption; HOMA-IR, homeostasis model
assessment – insulin resistance; HOMA-β, homeostatic model
assessment – cell function; HDL, high density lipoprotein; LDL,
low density lipoprotein. Mean ± SE. N = 8.

Mean ± SE

Range (Min-Max)

Age, y

24.1 ± 1.4

19-32

BMI, kg/m2
.
VO2MAX, ml×kg-1×min-1

22.4 ± 0.8

18.2-25.9

39.7 ± 2.0

34.9-49.1

Fasting Glucose, mg/dl

92.4 ± 3.1

81-109

Fasting Insulin, μIU/ml

8.4 ± 0.9

5-12

HOMA-IR

1.9 ± 0.2

1.1-2.6

HOMA-β

106.0 ± 16.6

62.8-180.8

Total Cholesterol, mg/dl

164.6 ± 9.6

140-217

HDL, mg/dl

48.0 ± 4.1

34-67

LDL, mg/dl

98.9 ± 10.2

73-161

Triglycerides, mg/dl

88.9 ± 11.0

51-143
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Table 7. Gene sequences of mRNA and miRNA, obtained from the Harvard Primer Bank.
Apoptotic linked gene-2 interacting protein X (Alix); Tumor Susceptibility Gene-101
(TSG-101); hepatocyte growth factor-regulated tyrosine kinase substrate (HGS); signal
transducing adaptor molecule (STAM); vesicle trafficking 1 (Vta1); vacuolar protein
sorting mutant (Vps4a); Myogenin (MyoG); myosin heavy chain (MHC).
Gene

Forward (5’-3’)

Reverse (5’-3’)

Alix
Clathrin
TSG-101
CD63
Dicer
Exportin-5
Drosha
HGS
STAM
VTA1
Vps4a
Rab11A
Rab27A
RAB27B
RAB35
Syntaxin 1A
Pax3
Pax7
MyoG
MHC

ATGGCGACATTCATCTCGGTG
ATTCTGCCAATTCGTTTTCAGGA
GAGAGCCAGCTCAAGAAAATGG
CAGTGGTCATCATCGCAGTG
GAGCTGTCCTATCAGATCAGGG
ATCCTGGAACACGTTGTCAAG
TGTCACAGAATGTCGTTCCAC
CTCCTGTTGGAGACAGATTGGG
AATCCCTTCGATCAGGATGTTGA
CTCCCCGCACAGTTCAAGAG
CCACGCTATCAAGTATGAGGC
CAACAAGAAGCATCCAGGTTGA
GCTTTGGGAGACTCTGGTGTA
TAGACTTTCGGGAAAAACGTGTG
TACTGTTGCGTTTTGCAGACA
CGAGACCGCTTCATGGATGAG
AGCTCGGCGGTGTTTTTATCA
ACCCCTGCCTAACCACATC
GGGGAAAACTACCTGCCTGTC
ATTGCTTCGTGGTGGACTCAA

CGCTTGGGTAAGTCTGCTGG
GCTTTCAGTGCAATTACTTTGCT
TGAGGTTCATTAGTTCCCTGGA
ATCGAAGCAGTGTGGTTGTTT
ACTTGTTGAGCAACCTGGTTT
CACTACAATTCGAGACAGAGCAT
GGGCCTAAAGGATGGTGCT
GTGTGGGTTCTTGTCGTTGAC
CGAGACTGACCAACTTTATCACA
AACGACAGTAATAAGCCACCAC
CCGTGTTTCTCTTTGCTTCGTA
GCACCTACAGCTCCACGATAAT
TCAATGCCCACTGTTGTGATAAA
AGAAGCTCTGTTGACTGGTGA
CCCCGATAATACGTGGAGGTG
ACTTGGAACGAACTTTGTTTGC
CTGCACAGGATCTTGGAGACG
GCGGCAAAGAATCTTGGAGAC
AGGCGCTCGATGTACTGGAT
GGCCATGTCTTCGATCCTGTC
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Table 8. Gene expression differences between
day 6 and day 8 for muscle differentiation markers
Pax3, Pax7, Myogenin (MyoG) and myosin heavy
chain (MHC). Data were controlled to Beta Actin.
N=4.
Day 6
Pax3
1.00 ± 0.13
Pax7
1.00 ± 0.11
MyoG 1.00 ± 0.01
MHC 1.00 ± 0.15

Day 8
0.90 ± 0.08
1.32 ± 0.64
0.88 ± 0.04
0.60 ± 0.04

P value
0.55
0.71
0.13
0.07
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Table 9. NanoSight average counts, separated by each 25 nm range. *p≤0.05. N=8.
Range (nm)
0-75.5
76.5-100.5
101.5-125.5
126.5-150.5
151.5-175.5
176.5-200.5
0-200.5 (total)

Control (1.0) ± SE
No Counts
1.00 ± 0.51
1.00 ± 0.44
1.00 ± 0.24
1.00 ± 0.15
1.00 ± 0.09
1.00 ± 0.11

EPS (Fold Change) ± SE
No Counts
0.28 ± 0.15
0.54 ± 0.24
0.64 ± 0.22
0.61 ± 0.16
0.69 ± 0.14
0.66 ± 0.14

P value
N/A
0.18
0.40
0.16
0.05*
0.03*
0.04*
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Con

Control
(2µl
ddH2O)

KN-92
(10µmol)

KN-93
(10µmol)

EPS

Control
(2µl
ddH2O)

KN-92
(10µmol)

KN-93
(10µmol)

Figure 15. Representation of the six conditions tested for each cell culture plate. Six
identical dishes were placed per subject (~75,000 cells/well) with 1 Con and 1 EPS plate
collected for 1) 30-min stimulation to validate EPS effectiveness, 2) 24-hour stimulation
for Western Blot analysis, and 3) 24-hour stimulation for rt-PCR analysis. Media was also
collected from each plate with 24-hour treatments, 8 ml/condition, for exosome isolation.
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Figure 16. Raw myosin heavy chain protein expression observed at day 6 and day 8
following differentiation. N=4.
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A.

Pilot Data

Day 6

Day 8

B.

Subject 6

Day 6

Day 8

Figure 17. Cell Stains in vitro to test differentiation of day 6 compared to day 8. Clear
myotubes were formed during preliminary findings from previous human subjects on day 8
vs. day 6 (A). and with the present investigation (B). MF-20 (Red) and DAPI (Blue).
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Figure 18. Phosphorylation of common in vivo exercise pathways following 30 min of
EPS. Calcium-calmodulin kinsase II (n=6) (A), P38 mitogen activated protein kinase (n=5)
(B), and adenosine monophosphate kinase (n=7) (C). Con (black) and EPS (gray). Data
presented represent Mean ± SE.
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Figure 19. Gene expression analysis of MVB biogenesis/ESCRT in control (black)
and EPS (gray) conditions. ESCRT-0 proteins hepatocyte growth factor- regulated
tyrosine kinase substrate (HGS) (A) clathrin (B), and signal transducing adaptor
molecule (STAM) (E), ESCRT-I proteins Tumor Susceptibility Gene-101 (TSG-101)
(C), accessory protein apoptotic linked gene-2 interacting protein X (Alix) (D),
ESCRT-III protein vesicle trafficking 1 (Vta1) (F), and vacuolar protein sorting mutant
(Vps4a) (G), and the tetraspanin CD-63 (H). Data presented represent Mean ± SE.
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Figure 20. Gene expression analysis of MVB/exosome release for Con (black) and EPS
(gray) subjects. Rab and syntaxin family proteins are associated with MVB fusion with
the membrane, leading to exosome release. Data presented represent Mean ± SE, n=8.
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Figure 21. Gene Expression analysis of the miRNA processing pathway drosha (A),
exportin-5 (B), and dicer (C). Con (black) and EPS (gray). Data presented represent
Mean ± SE, n=8.
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Figure 22. Western blot analysis of exosome surface markers after 24 h in skeletal
muscle (Left) and exosomes isolated in the media (Right). Markers include CD-63
(A,B), TSG-101 (C,D), Alix (E,F). and clathrin (G, undetected in exosome isolation).
Con (black) and EPS (gray). Data presented represent Mean ± SE, n=8.
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Figure 23. Gene Expression analysis of common in vivo pathways to identify exercise
response. Vascular endothelial growth factor (A), pyruvate dehydrogenase kinase 4 (B),
interleukin-6 (C), and peroxisome proliferator-activated receptor gamma coactivator 1alpha (D). Con (black) and EPS (gray). Data presented represent Mean ± SE, n=8.
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CHAPTER 5. CONCLUSION

Summary
In summary, the present work demonstrates several changes in response to acute
exercise in whole skeletal muscle: 1) MVB biogenesis gene expression is impaired at rest
with obesity, but able to increase in response to A+REx in LN and REx in LN and OB, 2)
miRNA processing gene expression changes in response to AEx and A+REx at 1 hr postexercise in LN, but no change in response to REx immediately and 3 hr post-exercise in
LN and OB, 3) VEGF and PGC-1α gene expression increases in response to AEx, A+REx,
and REx immediately following, 1 hr, and 3 hr post-exercise in LN and OB, 4) in OB, antiangiogenic signals are also increased in response to REx 3 hr post-exercise, 5) miRNA
related to angiogenesis are impaired at rest in OB, potentially leading to the diminished
vascularization associated with obesity, and are unchanged in response to moderate
intensity AEx, A+REx, and REx, and 6) exosome surface markers remain unchanged in
response to AEx and A+REx, with varying effects based on protein marker in response to
REx alone. Differences in skeletal muscle MVB pathway analysis in vitro via EPS and
CaMKII inhibition include: 1) CaMKII inhibition decreased PDK4 gene expression and
trended to an interaction effect to increase clathrin gene expression, 2) no changes in MVB
biogenesis, release, or miRNA processing with EPS or CaMKII inhibition, 3) trends for
increased and decreased exosome surface markers were observed with CaMKII inhibition,
and 4) quantification of exosomes isolated in the media were reduced in response to EPS
compared to control.
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Limitations and Future Directions
Project 1 – Acute AEx and A+REx. Limitations of project 1 include the timing of
biopsies post-exercise. As each subject served as their own control and biopsies were
removed from each leg at the same time point, we wanted to reduce the total number of
biopsies in a single day to three. Due to this, we selected 1 hr post-exercise as a time to
monitor changes to enzyme activity, from an initial project design regarding metabolic
enzyme activities following acute exercise. Future directions related to MVB biogenesis
and release should expand the type, time, and intensity of well-known interventions leading
to exercise adaptations to identify the potential role that MVB/exosomes play in acute
exercise bouts and training over time. To enable more time points, an emphasis should be
placed on one exercise modality, such as cycling.
Project 2 – LN and OB REx. Future directions for project 2 include a focus on the
content of exosomes between LN and OB subjects to determine potential therapeutic
targets in an OB population. Additionally, conducting proteomic and transcriptomic
analysis of exosomes based on surface marker could provide valuable information about
the response to REx in each group, such as hypertrophy or angiogenic signaling. Several
studies could be designed to confirm MVB/exosome release from whole human muscle,
starting

with

a

time-course

release

following

acute

exercise.

Ideally,

immunohistochemistry changes in response to acute exercise should be performed to
demonstrate a reduction of exosome surface markers, as previously observed in mice (52).
Samples should be mounted prior to and immediately following exercise to identify this
change. Differences between LN and OB would be likely, based on the altered signaling
identified in our study with MVB biogenesis and various miRNA related to angiogenesis.
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Project 3 – CaMKII inhibition and exosome release. Several limitations occurred
during project 3, including poorly differentiated cells, questionable use of antibiotics which
may block calcium signaling, and unknown effective doses of CaMKII inhibition with KN93 in human SkMCC.
Future research in vitro should investigate a time-course in human SkMCC response to
EPS related to MVB biogenesis and optimal MVB/exosome release from myoblasts and
myotubes separately (36). The future direction of human SkM exosomes isolated in vitro
will enable treatment of other cellular environments to determine “cross talk” potential. To
our knowledge, primary human SkM exosomes have not been used to identify changes in
other cells types (2, 36). One therapeutic target of interest is endothelial cells (EC).
Preliminary data from our lab has shown enhanced proliferation and migration of EC’s in
response to treatment with exosomes isolated from C2C12 SkM cultures. Other potential
targets related to exosomes isolated from EPS would be cardiomyocytes, hepatocytes, and
alveolar cells. The heart, liver, and lungs receive a large amount of blood during aerobic
exercise, making them ideal locations for SkM exosomes to interact in vivo. It is also
suggested to improve EPS protocols to enhance contraction of primary human skeletal
muscle cell lines. Identifying limiting factors for individual myotube contraction, such as
the use or disuse of antibiotics (43), or the optimal day of differentiation to fully formed
myotubes.
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